Expanding the scope of the nucleophile catalyzed aldol lactonization (NCALl) process and transformations of the resulting beta-lactones by Matla, Andrea Slava
  
 
 
 
EXPANDING THE SCOPE OF THE NUCLEOPHILE CATALYZED ALDOL 
LACTONIZATION (NCAL) PROCESS AND TRANSFORMATIONS OF THE 
RESULTING β−LACTONES 
 
A Thesis 
by 
ANDREA SLAVA MATLA  
 
 
Submitted to the Office of Graduate Studies of 
Texas A&M University 
in partial fulfillment of the requirements for the degree of  
MASTER OF SCIENCE 
 
 
May 2008 
 
 
Major Subject: Chemistry 
 
  
 
EXPANDING THE SCOPE OF THE NUCLEOPHILE CATALYZED ALDOL 
LACTONIZATION (NCAL) PROCESS AND TRANSFORMATIONS OF THE 
RESULTING β−LACTONES 
 
A Thesis 
by 
ANDREA SLAVA MATLA  
 
Submitted to the Office of Graduate Studies of 
Texas A&M University 
in partial fulfillment of the requirements for the degree of  
MASTER OF SCIENCE 
 
Approved by: 
Chair of Committee,  Daniel Romo 
Committee Members, Brian Connell 
 Gil Rosenthal 
Head of Department, David H. Russell 
 
 
May 2008 
 
Major Subject: Chemistry 
 iii 
ABSTRACT 
 
Expanding the Scope of the Nucleophile Catalyzed Aldol Lactonization (NCAL) Process 
and Transformations of the Resulting β-Lactones.  (May 2008) 
Andrea Slava Matla, B.S., University of Pittsburgh  
Chair of Advisory Committee: Dr. Daniel Romo 
 
Expanding the uses of the NCAL and finding the spectrum of substrates best 
suited for such a transformation has been the main effort of my research.  Previous 
studies had focused on aldedydes as the requisite functionality that would provide the 
needed electrophilicity in order to complete the aldol; however, recent advancements 
have introduced ketones as a viable carbonyl.  With an established protocol in hand, I set 
out to explore various substrates that could yield β-lactones in good to moderate yields 
such as amino acid derivatives, diones, and large cyclic formations as well as simple, 
straight chain acids with varying groups α to the ketone.  In general, I was able to 
establish a basic framework of substrates that are highly and/or moderately susceptible 
towards the NCAL and current studies continue to further expand the scope. 
In addition to making β-lactones, I investigated alkyl cuprates as soft 
nucleophiles to afford addition at the β carbon yielding a variety of acids.  Substrates for 
cuprate additions have been expanded to bulkier and multi-cyclic β-lactones and applied 
to the synthesis of a Merck IND intermediate.  Additions to bi- and tri-chloro β-lactones 
due to the presence of the resulting moity in natural products are currently being studied. 
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CHAPTER I 
INTRODUCTION:  RECENT ADVANCES IN ORGANOCATALYZED 
STEREOSELECTIVE ALDOL-LACTONIZATIONS
 
 
 
A.  Nucleophile (Lewis Base) Promoted Tandem Aldol-Lactonizations:  
Introduction and History 
 Modern day synthetic organic chemistry requires scientists to possess a vast 
arsenal of chemical tools which allow them to pursue larger, more interesting and more 
structurally complex compounds and/or natural products.  Tools such as catalysts, chiral 
reagents, established reactions and useful intermediates can greatly improve efficiency 
and cost when considering strategies toward total syntheses.  Cyclic esters, or lactones 
have been used to accomplish such challenges and have found great utility in this area.  
Similarly, there have been several advancements made in the synthesis of lactones, 
making their usefulness and applicability quite broad in chemical endeavors. 
 There are several methods to make β-lactones.  These range from the most basic 
approaches such as iodolactonization and bromolactonization to more ambitious routes 
such as Lewis acid promoted [2+2] cycloadditions or asymmetric aldol-lactonizations 
with chiral catalysts.  As the name implies, an aldol-lactonization process merges two of 
the most useful reactions in organic synthesis.  In addition, adding Lewis bases, Lewis 
acids or organocatalysts improve the efficiency and propels both of these                                               
                   
                                                 
  This thesis follows the style of the Journal of the American Chemical Society. 
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transformations into powerful methodologies.  Here, we will explore some of the origins, 
applications and advancements made in organocatalyzed aldol-lactonizations and each of 
the respective catalyst sub-categories.     
Scheme 1.1 
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B.  Lewis Bases as Chiral Nucleophilic Promoters 
 In 1966, Borrmann and Wegler1 first synthesized optically active β-lactones via 
an aldol-lactonization process consisting of α-chlorinated aldehydes, a chiral Lewis base 
(nucleophilic promoter) and halogenated ketones in which ketene would be generated in 
situ.  The β-lactones were isolated in moderate to good yields with enantioselectivity up 
to 72% (Table 1). 
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Table 1.  Examples from the work of Borrmann and Wegler. 
O
X
R1
R2Cl3C H
O
(-)-brucine
O
OR
1
R2
H
Cl3C
1.3
50% yield
up to 72% ee
CCl4, 0
oC
(-)-Brucine
1.1 1.2
 
entry R1 R2 yield (%) 
1 H H 69 
2 Cl Cl 39 
3 H 
O
Cl
Cl
 
63 
4 H 
Cl
O
 
45 
 
 
 In 1982, Wynberg and Staring2 building on the precedent of Borrmann and 
Wegler and reported the use pseudo-enantiomeric cinchona alkaloids, specifically 
quinidine 1.5a and quinine 1.5b, to catalyze the net [2+2] cycloaddition of chloral 1.1 
and ketene 1.2 and obtain the β-(trichloromethyl)-β-propiolactone 1.3 in good yields and 
high enantiomeric excess.  Wynberg also noted that with proper choice of catalyst (i.e. 
pseudo-enantiomer quinine) the enantiomeric β-lactone could be produced (Table 2). 
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Table 2.  Wynberg's seminal studies.           
H CCl3
O
OCH2C
quinidine 1.5a
-50 oC, toluene O
O
CCl3
H
1.1 1.2 1.4  
R1
R2
O
 
% ee 
 
R1 R2 quinidine quinine yield 
(%) 
CCl3 H 98 76 89 
CCl2H H 45  67 
CCl2CH3 H 91 76 95 
CCl2CH2CH3 H 89 70 87 
CCl2C6H5 H 90 68 89 
CCl3 CH3 94 85 72 
CCl3 C6H4Cl-p 90 65 68 
CCl3 C6H4NO2-p 89 65 95 
 
 
 This important advance in the field of catalytic, asymmetric β-lactone synthesis 
reintroduced them as useful chiral reagents and intermediates for organic synthesis and 
continues to stand as a benchmark in this area.  Although influential, Wynberg's method 
requires the use of a ketene generator and activated highly electon deficient 
aldehydes/ketones.  Because of these limitations, several other groups3,4 were prompted 
to expand upon and improve this promising advancement.  Therefore in 1986, Brady 
employed ketene in a presumed [2+2] cycloaddition to aldehydes and ketones to form 
substituted benzofurans following decarboxylation of β-lactones (Scheme 1.2).5  
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 Although Brady presents this as an initial [2+2] cycloaddition, another 
mechanism may be operative here.  The generated ketenes were never identified and 
excess triethylamine (TEA) could lead to the formation of a possible ammonium enolate 
intermediate, leading to an aldol-lactonization process to deliver the presumed β-lactone.  
Although Brady found evidence for a [2+2] cycloaddition from trapping the 
phenoxyketene 1.6 with cyclopentadine, the product 1.10 was isolated in only 45% 
yield.  
 Possibility of a simultaneous generation of an ammonium enolate intermediate 
cannot be completely disregarded since tertiary amines have been shown to promote 
aldol-lactonization type pathways via an ammonium enolate (vide infra).  One such 
example has been illustrated by Calter et al. in 1996 when they used cinchona alkaloid 
catalysts and their derivatives to catalyze a dimerization reaction of monosubstituted 
ketenes generated in situ to obtain β-lactones with high enantioselectivity.  The 
 6 
intermediate obtained from this transformation has been used as a synthon for 
polypropionate synthesis.1c,d 
Scheme 1.3 
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 Also classified as a [2+2] cycloaddition/dimerization, an aldol-lactonization can 
efficiently operate in forming 1.13 from 1.12.  Continuing with the ketene dimerizations, 
in 2003 they reported the first examples of catalytic, asymmetric dimerization of in situ 
ketenes generated from acid halides.  Cinchona alkaloids were used as the catalysts for 
these transformations and formation of the acyl ammonium would increase the 
electrophilicity of the carbonyl, thus facilitating an aldol-lactonization mechanism. 
 
 1. Cinchona Alkaloid Catalysts 
 Cinchona Alkaloids are a family of natural products which are isolated from the 
bark of cinchona trees which are all indigenous to the slopes of the Andes in South 
America6.  Wynberg was the first to use them to catalyze the net [2+2] cycloaddition 
towards the formation of optically active β-lactones.  Although a good foundation, their 
method was limited to activated carbonyl compounds and use of a ketene generator thus 
severely limiting the scope.    
 7 
 In order to advance the utility of this methodology, the Romo group has been 
engaged in exploiting these catalysts to access β-lactones in recent years.  Noting the 
drawback in Wynberg's method, conditions were developed which would allow the 
formation of in situ generated ketene via the dehydrochlorination of acid chlorides.  In 
the end, our group was able to extend Wynberg's approach and successfully 
demonstrated use of activated aldehydes through in situ generated ketenes7 to produce 
optically active β-lactones (Table 3).  In addition, the use of non-activated aldehydes has 
been exploited in the intramolecular nucleophile catalyzed aldol lactonization (NCAL).8  
Aldehyde acids are used in conjunction with Mukaiyama's reagent as carboxylate 
activator and cinchona alkaloid derivatives as catalysts to deliver bicyclic β-lactones 
with high enantiomeric excess (Figure 1). 
 The catalyst used here can be either quinidine or quinine.  We then became 
interested in the catalysts themselves and decided to study their conformations in 
solution to gain insight into the high enentioselectivity of these reactions.  It was 
determined that although a variety of low energy conformations are operative,9 only 
small variations in enantioselectivity were observed for several variations at the C9 
position of quinidine.10  The cinchona alkaloids have proven to be quite effective 
towards aldehyde-acid conversion to β-lactone, however they are not as useful when 
applied to the corresponding keto-acid substrates.  Currently, our group is expanding 
studies of the NCAL methodology towards keto-acids and is making good progress (see 
Chapter III).  
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 2.  Cinchona Alkaloid/Lewis Acid Combinations 
 In addition to using cinchona alkaloids by themselves, Nelson has combined 
them with Lewis acids in order to induce formation of β-lactones.  Although somewhat 
 
Table 3.  Catalytic asymmetric intramolecular NCAL reactions leading to bicyclic  
β-lactones. 
N
R
X
Y
1.15a: R = n-Pr;
X = Br; Y = OTf
1.15b: R = Me;
X = Cl; Y = OTf
CHO
CO2H
R
O
O
1.16: n=1
1.17: n=2
4.0 eq i-Pr2NEt
CH3CN or CH2Cl2
25 oC, 48 h
10 mol% O-Ac Quinidine
3.0 eq 1.15a or 1.15b
n( ) ( )
n
R
1.14
 
entry β-lactone cmpd. no. method
a % yield % eeb config. 
1 
O
O
 
1.16a B 82 92 1R, 2Sc 
2 
O
O
O
O
 
1.16b A 74 92 3R, 4Sc 
4 
O
O
MeO2C
MeO2C  
1.16c A 74 91 1R, 2Sd 
5 
O
O
 
1.16d A 45 90 1R, 2Sc 
6 
O
O
 
1.16e A 51 86 1S, 2Re 
7 
O
OMeO2C
MeO2C
 
1.17 B 76 98 1R, 2Sd 
aMethod A: Pyridinium salt 1.15a was employed in CH2Cl2 for 48 h.
  Method B: Pyridinium salt 
1.15b in CH3CN for 108 h.
  bEnantiomeric excess was determined by chiral GC analysis.  cAbsolute 
configuration was assigned by reduction to the known diol1 and comparison of optical rotations.  
dPredicted based on analogy to that determined for β-lactones 1.16a and 1.16b.  eO-Ac-Quinine used as 
the chiral catalyst. 
                                                 
1  Inoguchi, K.; Fujie, N.; Yoshikawa, K.; Achiwa, K. Chem. Pharm. Bull. 1992, 40, 2921-2926. 
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Figure 1.  Proposed NCAL mechanism. 
 
mechanistically distinct, in 2004, they used cinchona alkaloids to catalyze acid chloride-
aldehyde cyclocondensation (AAC) reactions.  They were able to obtain high enantio- 
and diastereoselection in most cases.  They also tested various Lewis acids as cocatalysts 
in their reactions and lithium perchlorate emerged as particularly effective for 
commencing the AAC reaction.  Additionally, the Nelson group investigated variations 
at C9 of the alkaloids and found the TMS protected alcohol to be most ideal for both 
quinidine (TMSQ) and quinine (TMSq).11  With solvent optimization and Lewis acid 
stoicheometry modulation, they developed an effective procedure for AAC reactions 
towards β-lactones (Table 4).  
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Table 4.  Cinchona alkaloid/LiClO4-catalyzed AAC reactions. 
H R2
O
Cl
O
R1
10 mol% TMSQ, LiClO4,
i-Pr2NEt, CH2Cl2/ether,
-78oC -40oC
O
O
R2R1
1.24 1.25 1.26  
entry R1 R2 %eea,b %dec yield 
1 H cC6H11 94
d - 85 
2 H CMe3 96
e - 71 
3 H CH2CH2Ph 92 - 80 
4 Me cC6H11 97
f >96 74 
5 Me oC6H4Cl >99 96 80 
 a Enantiomer ratios determined by chiral GLC or HPLC.  b Minor enantiomer not observed for 
values >99%.  c Diastereomer ratios determined by 1H NMR of crude product mixtures. d 90% ee using 
TMSq as catalyst. e 95% ee using TMSq as catalyst. f 96% ee using TMSq as catalyst. 
 
 Two years later, Nelson expanded upon his own studies to provide a general 
methodology applicable towards obtaining optically active syn- or anti- β-lactones 
derived from optically active aldehydes.  The mechanism is based upon his 
aforementioned AAC type reactions and provides access to various polypropionate 
substrates (Table 5).12   
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Table 5.  Matched and mismatched AAC Reactions. 
entry aldehydea β-lactoneb % de (% yield)
c 
1 H CH2CH2Ph
O OTMS
Me  
CH2CH2Ph
OTMS
Me
O
O
Me
 
≥95 (83) 
2 H CH2CH2Ph
O OBn
Me  
CH2CH2Ph
OBn
Me
O
O
Me
 
≥95 (78) 
3 H CH2CH2Ph
O OTMS
Me  
CH2CH2Ph
OTMS
Me
O
O
Me
 
91 (81) 
4 H CH2CH2Ph
O OPMB
Me  
CH2CH2Ph
OPMB
Me
O
O
Me
 
92 (81) 
a Catalyst (10 mol %) TMS-quinine, entries 1 and 2; TMS-quinidine, entries 3 and 4.  b Stereochemical 
asignments based on X-ray structure determinations of derivatives of entry 4's β-lactone and comparison 
of 1H coupling constants.  c Diastereomeric ratios determined by HPLC or 1H-NMR analysis of crude 
reaction mixtures. 
 
 
 Similar to Nelson's studies, Calter has also used a combination of cinchona 
alkaloids and achiral Lewis acids to catalyze the asymmetric condensation of aromatic 
aldehydes with acid chlorides.  They screened a variety of lanthanide and 
pseudolanthanide triflates which presumably co-catalyzed the addition of substitued 
ketenes to unactivated aldehydes (Table 6).  In some cases, they were able to obtain the 
trans-β-lactone, which represents the first direct access to such systems with high 
diastereoselectivity.13 
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Table 6.  Yields and selectivities for the formation of β-lactones 1.29a-d. 
Cl
OR
O
1.27
1.5 equiv
H Ar
O
1.28
1 equiv
20 mol%, TMSQ,
15 mol% Er(OTf)3
1.65 equiv HB,
CH2Cl2, 0
oC
O
O
RO Ar
1.29a-d
O
O
RO Ar
1.30a-d  
products 1.29/1.30a % yield of 1.29b (% ee)c  % yield of 1.30b (% ee)c 
a: R = Ph, Ar = Ph 88:12 58 (>99) nd 
b: R = Ph,  
Ar = 4-
bromophenyl 
88:12 55 (>99) nd 
c: R = Ph, 
Ar = 3-chlorophenyl 
92:8 88 (>99) 5 (nd) 
d: R = Bn, 
Ar = 4-cyanophenyl 
87:13 68 (>99)d nd 
a
 Determined by 1H NMR analysis of the unpurified reaction mixture. b Yield of puified compound. c 
Determined by HPLC analysis of purified isomer. d Reaction performed with TMS-quinine as catalyst; the 
enantiomer of 1.29d was the major product. 
 
 
 3.  N-Heterocyclic Carbenes (NHC) 
 Carbenes have been recognized as important reaction intermediates.  In 1991, 
Arduengo reported the first synthesis, structure and characterization of crystalline N-
heterocyclic carbene derived from the deprotonation of 1,3-di-1-adamantylimidazolium 
chloride 1.31 (Scheme 1.5). 14   As a carbene, it is quite reactive however it also enjoys 
both steric and electronic stability.  As a result, these NHC's have enjoyed widespread 
use and applications as ligands in transition metal catalysis, as nucleophiles and as 
catalysts for conjugate umpolung chemistry of α,β-unsaturated aldehydes resulting in β- 
and γ- lactones.15  
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Scheme 1.4 
N
N
H
H
H Cl
N
N
H
H
NaH
THF
cat. DMSO
H2 NaCl
1.31 1.32  
 
  a. Bicyclic β-Lactones via Aldol-Lactonizations 
 Currently NHC's are being explored as catalysts in the formation of β-lactones 
via an aldol-lactonization process.  Recently, Glorius found conditions for the formation 
of β-lactones from ketones and α, β-unsaturated aldehydes using catalytic amounts of 
IMes∗•HCl via a conjugate umpolung (Table 7).15   
 
 
 
 
 
 
 
 
                                                 
∗ bis(1,3-(2,4,6-trimethylphenyl)imidazol-2-ylidene). 
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Scheme 1.5 
N NMes Mes
N
N
Mes
Mes
R1
O
H
N
N
Mes
Mes
R1
OH
N
N
Mes
Mes
R1
OH
N
N
Mes
Mes
R1
O
N
N
Mes
Mes
R3
O
R1
O
R2
R1 H
O
O
O
R2
R3 R
1
1.33
1.34
1.35
1.36a1.36b
1.37
1.39
1.40
R3 R2
O
1.38
 
 
Table 7.  β-lactone formation by conjugate umpolung.a 
entry R1 R2 yield (%) ratiob l/u  
1 Me CF3 34 60:40 
2 Pr CF3 45 55:45 
3 i-Pr CF3 48 62:38 
4 Ph CF3 30 70:30 
5 i-Pr CO2Me 22
c 71:29 
a
 General reaction conditions: IMes•HCl (0.05 mmol), TEA (2.0 mmol), toluene (2.5 mL), α,β-unsaturated 
aldehyde (1.0 mmol), ketone (1.0 mmol), 60 oC, 16 h.  b Determined by GC-MS.  c IMes•HCl (0.1 mmol), 
DBU (0.1 mmol). 
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 In 2006, Nair also employed IMes to catalyze the formation of cyclopentenes via 
an unstable β-lactone which undergoes a retro [2+2] to decarboxylate.16  Using α,β-
unsaturated aldehydes and ketones, they isolate the desired 1,3,4-trisubstitued 
cyclopentnes in moderate yields.  The intermediate β-lactone is proposed to form via an 
aldol-lactonization process, however it was never isolated, just observed via IR 
spectroscopy with a time-dependent disappearance of the characteristic β-lactone peak at 
1822 cm-1. 
 
Scheme 1.6 
R1
O
H
R2
O
R3
6 mol %
IMes HCl
12 mol % DBU,
THF, 25 oC, 8 h
O
R2
R1
R3
O
-CO2
R3
R2R1
1.41 1.42 1.43 1.44  
 
 Scheidt and co-workers expanded upon this and found that several triazolium 
salts were also able to catalyze the formation of cyclopentenes and a few optically active 
β-lactones from aliphatic diketones albeit the latter in moderate yields (Table 8).17      
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Table 8.  Substrate scope. 
10 mol% 1.47
i-Pr2EtN (1 equiv)
CH2Cl2, 40
oC
O
N
N
N
Ph
Ph
Me
Me
Me
BF4
1.47, triazolium
catalyst
O
H
R
R1
RO
O
1.45
R
R
R1
O
1.46
 
entry R R1 cyclopentene yield (%) ee (%)a 
1 Ph Et 
Ph
Ph
Et
O
 
73 90 
2 Ph allyl 
Ph
Ph
O
 
70 83 
3 O H
PhO
O
Ph
Me
 
Ph
Ph
O
Me
 
69 83 
4b O
H
PhO
O
Ph Ph  
Ph
Ph
O
Ph  
64 82 
5b O H
O
O
Me
Bn
Bn  
O
HMe
Bn
O
Bn
O
 
65c 93 
6b 
O
O
Me
H
O
 
O
HMe
O
O
 
51c 96 
a Determined by HPLC Chiracel AD-H.  b 20 mol % of the triazolium catalyst.  c Diastereomeric ratio = 
20:1.  Relative stereochemistry of β-lactones determined by NOE or X-ray crystallography.   
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  b.  Bicyclic γ-Butyrolactones via Aldol-Lactonizations 
 Similar to the way that IMes catalyzes the stereospecific synthesis of β-lactones, 
it can catalyze the synthesis of γ-lactones if the base, solvent and temperature are 
optimized. In 2004, Bode studied the formation of homoenolates derived from α,β-
unsaturated aldehydes and the subsequent generation of γ-butyrolactones (Table 9).  
They also obtained corresponding lactones in moderate yields and diastereoselectivities 
using a variety of NHC catalysts18. 
 
Table 9.  Direct, catalytic annulations of aldehydes and enalsa. 
R
O
H
CHO
R1
8 mol % IMes HCl,
7 mol % of DBU
10:1 THF/t-BuOH,
25 oC, 15 h
O
O
R
R1
1.48 1.49 1.50  
entry R R1 drb yield (%)c 
1 Ph Br 4:1 79 
2 Ph CO2Me 5:1 87 
3 4-MeOC6H4 Br 4:1 76 
4 4-MeOC6H4 H 4:1 65 
5 TIPS
 
CO2Me 3:1 41 
a Reaction conditions:  1.0 mmol enal, 0.5 M in 10:1 THF/ t-BuOH at 25 oC for 15 h, 8 mol % IMes•HCl, 
7 mol % DBU, 2 equiv of aldehyde.  b Determined by 1H NMR analysis of unpurified reactions mixtures. c 
Combined yield of both diastereomers after chromatography. d Concentration = 0.1 M. e Performed with 
15 mol % IMes•HCl, 14 mol % DBU. f The enal was added over 3 h. 
 
 
 Glorius15 studied the formation of γ-lactones extensively and found that when 
activated ketones were used, high yields and moderate diastereomeric ratios were 
obtained (Table 10).  They also studied a variety of substrates that could be subjected to 
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the conjugate umpolung of α,β-unsaturated aldehydes and established a useful method 
for the formation of such functionalities. 
 
Table 10.  Reaction of alkyl-substituted α,β-unsaturated aldehydes with ketonesa. 
R1 H
O
Ph R2
O
O
R1 Ph
R2
O
O
R1 R2
Ph
O
1.51 1.52 1.53a 1.53b
IMes HCl,
DBU, THF
25 oC, 16 h
 
entry R1 R2 yield (%) 
ratio 
(1.53a/1.53b)b 
1 Me CF3 82 81:19
c 
2 Pr CF3 90 84:16
c 
3 i-Pr CF3 66 93:7
d 
4 Me CO2Me 87 68:32
c 
5e Pr CO2Me 71 67:33
c 
6f i-Pr CO2Me 72 65:35
d 
a General reaction conditions:  IMes•HCl (0.05 mmol), DBU (0.05 mmol), α,β-unsaturated aldehyde (0.5 
mmol), ketone (1.0 mmol), THF (2.5 mL), r. t., 16 h.  Yield given for the isolated mixture of 
diastereomers.  b Determined by GC-MS. c 1.53a = like, 1.53b = unlike. d 1.53a = unlike, 1.53b = like. e 
DBU (0.25 mmol), 50 oC.  f DBU (0.25 mmol). 
 
 
 4.  Pyridine Derivatives 
 Recently, there has been more exploration and variation in the synthesis of β-
lactones, especially under catalytic conditions.  Currently, investigations involve the use 
of pyridine catalysts and some have reported good to moderate yields and high 
diastereoselectivites.  One such example comes from Merlic and his studies using 
tertiary amines as catalysts.  Electron-rich aldehydes were reacted with ketenes which 
were derived from chromium carbene complexes to yield the β-lactones and in some 
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cases, enol ethers from decarboxylation (Table 11).  They screened a number of catalysts 
including cinchona-like alkaloids which have been known to catalyze such reactions 
with activated aldehydes.  Most of the Lewis bases failed except for DBU, DABCO and 
DMAP∗, which delivered the highest yield and best diastereomeric ratio.19   
 
Table 11.  Results of ketene-aldehyde coupling. 
Ph OMe
Cr(CO)5
R H
O DMAP
hν, THF
30 psi CO
O
O
R
OMe
Ph
1.54 1.55 1.56 (syn)
O
O
R
Ph
OMe
1.56' (anti)  
entry aldehyde product 
yield of 1.56 (%) 
(syn/anti) 
1 propionaldehyde 1.56a/1.56a' 53 (15/1) 
2 acetaldehyde 1.56b/1.56b' 55 (8/1) 
3 n-butyraldehyde 1.56c/1.56c' 43 (23/1) 
4 isobutyraldehyde 1.56d/1.56d' 35 (4/1) 
5 benzaldehyde 1.56e/1.56e' 33 (15/1) 
 
 Fu and co-workers have been exploring the use of planar-chiral derivatives of 
DMAP as nucleophilic catalysts for enantioselective processes.20  They then applied this 
idea towards C-acylation processes and found that several pyridine derivatives catalyze 
the asymmetric synthesis of β-lactones from disubstituted ketenes. They found that a 
chiral 4-pyrrolidinopyridine (PPY) derivative 1.60 gave the best enantioselectivity which 
is the first catalyst to date that has been found most effective for generating α,α-
disubstituted β-lactones from disubstitued ketenes (Table 12).20d 
                                                 
∗ DBU:  1,8-diazadicyclo[5.4.0]undec-7-ene.  DABCO:  1,4-diazabicyclo[2.2.2]octane.  DMAP:  N,N-4-
dimethylaminopyridine. 
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Table 12.  Catalytic asymmetric synthesis of β-lactones by cycloadditions of 
disubstituted ketenes with aldehydes. 
 
 
 
entry R3 ee (%)a yield (%)a 
1 Ph 91 92 
2 2-naphthyl 89 77 
3 4-(CF3)C6H4 80 74 
4 4-(MeCO)C6H4 81 76 
5 4-MeC6H4 89 67 
a Average of two runs. 
 
 Romo and coworkers recently developed a biscyclization method to synthesize 
bicyclic and tricyclic β-lactones starting with readily available keto-acids.21  This work 
expands upon their previous studies with aldehyde acids and nucleophile catalyzed aldol 
lactonizations.  Although this is not an enantioselective process yet, the 
diastereoselectivity is quite acceptable in most cases.  PPY is used as the catalyst as 
opposed to the cinchona alkaloids which were previously employed for the aldehyde 
substrates (Table 13).   
 
 
 
 
 
 
O
•
EtEt
H R3
O
1.57 1.58
THF, -78 oC
5% (-)-1.60 O
O
Et H
R3Et
1.59
Fe
Me
N
N
Me
Me Me
Me
1.60
chiral PPY derivative
 21 
a Yields refer to isolated (silica gel), purified product. b 1.5 equiv PPY, 1.5 equiv 1.15a, 
and 2.5 equiv Hunig's base were employed. c Relative stereochemical assignment of 
bicyclic β-lactones is based on either strain arguments, nOe, x-ray analysis, coupling 
constant analysis of derivatives or analogy to dihydroplakevulin. 
Table 13.  Carbocycle fused β-lactones obtained via the intramolecular NCAL reaction 
of keto-acid substrates. 
 
1.62
i-Pr2NEt (2.5 equiv)
CH2Cl2
23 oC, 12 h1.61 (n = 1, 2)
PPY (1.5 equiv)
O
O
R1
R2
H
n
R3
CO2H
R1
+
n
N
n-Pr
Br
OTf
O
R2R3
1.15a (1.5 equiv)
O
OH
Ph
entry keto acid b-lactonea % yieldb drd
1
O
Me
O
H
TBSO
O
Me
OH
Ph
O
O
Me
H
TBSO
O
O
H
2
3
4
5
6
58
51
75c
67
61
70
-
2:1
~1:1
>19:1
>19:1
>19:1
O
CO2H
Ph
O
CO2H
Me
TBSO
O
CO2H
MePh
O
CO2H
O
CO2H
Me
OTBS
2
O
O
CO2Et
O
CO2H
2
CO2Et
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 Since PPY is not a chiral catalyst and no enantioselectivity is observed, we can 
not confirm an aldol-lactonization pathway.  We favor an aldol-lactonization route for 
several reasons.  Mainly, we observed high diastereoselectivity with β-substituted keto-
acid substrates which is consistent with A1,3 strain for an intermediate ammonium 
enolate.21  A [2+2] cycloaddition pathway would not have such A1,3 strain and thus no 
diastereoselectivity would be observed (Figure 2).  Also, we suggest nucleophile 
involvement based on improved efficiency with more nucleophilic promoters.   
 
H
O
O
NH2R3
CH3
H
R
O
H
R
CH3
H
NR3
OA1,3
H
O
CH3
H
R
O
•
NCAL mechanism [2+2] cycloaddition
1.63 1.64 1.65  
Figure 2.  Rational for high diastereoselectivity  in β-substituted acids. 
 
 Also, identifying discrete ketene intermediates should provide a conclusive 
result.  Although none were observed by in situ IR spectroscopy to date, we cannot 
exclude the existence of such fleeting intermediates.  Studies are currently underway to 
expand this methodology into an asymmetric process under catalytic conditions. 
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C. Applications 
 β-lactones are highly versatile; they are represented in natural products as 
themselves or are used as intermediates towards the synthesis of natural products (Figure 
3).12,22  A few recent examples that utilize an organocatalyzed aldol-lactonization 
pathway are presented below. 
 
HO
(CH2)15CH3
OH
CO2Me
(+)-dihydroplakevulin A
(Romo, 2007, ref . 16)
H
N O
O
O
HCl Me OH
salinosporamide
(Romo, 2007, ref. 21b)
OH
F
O
Merck IND
(Romo, 2007, ref. 18)
MeMeMeMeMeMe
O
OH
Me
O
siphonarienfuranone
(Calter, 2001, ref. 21c)
N
N
O
Me
H
(-)-rhazinilam
(Nelson, 2006, ref . 18)
Me
Me
OMe
Me
OH O
Me
O
(-)-pironetin
(Nelson, 2006, ref. 21a)
 
Figure 3.  Natural products or intermediates derived from a β-lactone made by an aldol-
lactonization type mechanism. 
 
D. Summary 
 Aldol-lactonizations can be catalyzed in a variety of ways, utilizing different 
types of catalysts depending on the desired stereochemistry and conditions.  Whether it 
be cinchona alkaloids, pyridine derivatives or the more recent NHCs, methods to 
 24 
accomplish the aldol-lactonization prove to be diverse and more effective.  The synthetic 
community calls for such variety in methods as our targets become more complicated 
and the need for choice for methodology more demanding.  Whether for the production 
of intermediates or being targets themselves, β-lactones continue to be highly utilized 
and possessing a diverse arsenal of chemical reactions to accomplish such 
transformations is undoubtedly necessary.   
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CHAPTER II 
CUPRATE ADDITIONS TO β-LACTONES 
 
A. Introduction:  Dual Electrophilic Character of β-Lactones 
 β-Lactones are unique, strained, four membered cyclic esters with a 
bielectrophilic character.  The dual reactivity of the β-lactones is derived from their 
inherent structure in which nucleophilic attack can lead to either acyl C-O cleavage or 
alkyl C-O cleavage (Figure 3).23  Appealing to hard/soft acid base theory, the carbonyl 
carbon is characterized as hard when compared to the β-carbon.  As such, if one 
carefully engineers the reagent, hard nucleophiles will lead to acylation while soft 
nucelophiles will lead to alkylation (Figure 4). 
 
R1 OH
Nuc
R2
O
O
O
R2R
1
Nuc: Nuc:
R1 Nuc
OH
R2
O
acyl C-O cleavage
(hard nucleophiles)
alkyl cleavage
(soft nucleophiles)2.1 2.2 2.3  
 
Figure 4. Dual reactivity of β-lactones. 
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B.  Background 
 1. Previous Cuprate Additions to β-Lactones  
 Historically, Normant (R2CuMgX) reagents
24 have been used to react with 
various β-lactones via C-O cleavage leading to an acid as Fujisawa,25 Normant26 and 
Vederas27 have shown.  The reaction has been successful in converting various methyl 
substituted β-lactones with decreasing yields as more steric bulk was added to the 
lactone (Scheme 2.1).  A variety of nucleophiles have also been tried, however aryl 
cuprate addition was often compromised by lower conversion and 1,2-addition.25f, 28   
 
Scheme 2.1 
O
O
(CH3)n R2CuMgBr R OH
O
(CH3)n
2.4 2.5 2.6  
 
 In 2002, Nelson28a and co-workers established a general protocol in which they 
were able to access several acids derived from the requisite β-lactone.  They used 
commercially available Grignard reagents to generate the cuprate in situ and isolated 
enantiomerically enriched β-lactones in good yields (74-94%).  They also reported lower 
yields when using cuprates derived from aryl and vinyl Grignard reagents while larger 
(isopropyl- or tert-butylmagnesium bromide) Grignard reagents required addition of 5 
mol% of CuBr•DMS.    
 
 27 
Scheme 2.2 
O
O
R1
R2MgBr, TMSCl
CuBr DMS,
THF, -30 oC
HO R1
O R2
2.8
(74 - 94%)
2.7
 
 
 2.  Background on the Merck IND and Previous Syntheses 
 In 2002, scientists at Merck published results detailing their isolation and route 
towards the asymmetric synthesis of (+)-trans-3-hydroxymethyl-4-(3-fluorophenyl)-
cyclopentanone 2.9 (Merck IND).  The cyclopentanone 2.9 was viewed as an advanced 
intermediate towards the preparation of a drug, 2.10 that would provide a novel method 
to treat HIV (Scheme 2.3).29  
Scheme 2.3 
NN
N
N CO2H
F
NN
NH
O
FHO
H2N CO2H
2.10
2.9
2.11 2.12
 
 Compound 2.10 was found to be a CCR5 antagonist, which will function to block 
the primary co-receptor that is needed on macrophages, monocytes, and primary T-cells 
when they are infected by the HIV-1 virus.  If this receptor, CCR5 is blocked with its 
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antagonist, it will prevent infection of host cells by the HIV virus.  In an effort to 
complete 2.10, medicinal chemists at Merck completed the large scale multistep 
synthesis of 2.9 in a total of 9 steps.  Their asymmetric synthesis was highlighted by a 
Mo-catalyzed alkylation in order to induce the proper sterochemistry at the first chiral 
center and then a diastereoslective Cu-catalyzed intramolecular cyclopropanation which 
allowed them to set the second stereocenter.  Lastly, they were able to develop a one-pot 
ring-opening/deprotection/hydrolysis/decarboxylation sequence which produced the 
desired IND intermediate in good yield.30 
 
Scheme 2.4 
MeO O
O
F
10 mol% Mo(CO)6,
10 mol% Trost ligand,
NaCH(CO2Me),
toluene, 90 oC
MeO OMe
F
OO
96-97% ee
84-91% yield
2.14
2.13
a) NaOH, HCl
b) CDI, MgCl2,
KO2CCH2CO2Me
c) p-AcNHphenyl-
sulfonylazide,
TEA, 1,2-DCE
N2 F
MeO
O O
2.15
(74%over 3 steps)
1 mol%
[(MeCN)4Cu]PF6,
1,2-DCE, 80 oC
OO
MeO
F
2.16
98% yield
4.5:1 dr
NaOAc, HOAc
110oC, then
DMF and NaOH 2.9
(86-94%)
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C.  Main Strategy and Methods 
 
 1.  Cuprate Additions to Bicyclic β-Lactones 
 We began our studies with bicyclic β-lactone 2.1731 and screened a variety of 
cuprates beginning with methyl cuprate using Nelson's established protocol (Table 1).  
At first, we obtained only poor results and minimal conversion presumably due to the 
extreme sensitivity of the cuprate to moisture and discrepancies in the titer 
(concentration) of our Grignard solutions which were used to form the cuprate prior to 
use.  In order to obtain better results, we varied time and temperature in order to 
determine which combination would lead to conversion (Table 14). 
 
Table 14.  Initial trials with methyl cuprate additions.  
O
O
O
O
MeMgBr, TMSCl
CuBr DMS, THF,
-50 oC X O
O
O
OH
Me
2.182.17  
entry X (°C) time (h) result* 
1 0 3.5 SM 
2 10 4.5 SM 
3 20 5 SM 
4 25 5.5 SM 
5 25 6.25 SM 
6 25 17.5 37% product 
* result based on crude 1H-NMR. 
 
 Next, we set out to find conditions that would optimize our result and produce 
higher yields.  In addition, we saw the appearance of a consistent by-product which was 
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determined to be the bromide substituted acid 2.19.  In order to maximize our desired 
yield and minimize the production of the side product, we varied the ethereal solvent, 
temperature, methyl source and copper reagent (Table 15).   
 
Table 15.  Optimization of methyl cuprate addition. 
O
O
O
O
conditions
O
O
O
OH
Me
2.18a
(product)
2.17
16 h
O
O
O
OH
Br
2.19
(by-product)  
entry solvent methyl source copper source temperature (oC) prod : by-product 
1 ether MeMgBr CuBr•DMS -42 → 20 0% : 25% 
2 DME MeMgBr CuBr•DMS -42 → 20 0% : 65% 
3 THF MeMgBr CuBr•DMS -42 →20 55% : 5% 
4 THF MeLi CuCN -78 → 0 2% : 0% 
5 THF MeMgBr CuI -30 → 0 SM 
 
 The efficiency of addition was quite sensitive to the stoichiometry of copper 
reagent and magnesium bromide, as noted by our group23 and in the literature28.  After 
screening various amounts, we determined that 3.0 equivalents of cuprate (via 
CuBr•DMS complex and MeMgBr) was necessary for optimal conversion.  A 
homogeneous, clear solution was used as an indicator for proper cuprate conversion (as 
tested against various substrates such as α,β-unsaturated carbonyls).  Freshly distilled 
THF over Na and benzoquinone was found to be an ideal solvent and     -42 oC warming 
to -5 oC over 2 hours were determined to be the optimal conditions.  After our success in 
methyl additions, we ventured to explore more bulky alkyl and aryl nucleophiles (Table 
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16).  When the cuprate derived from CuBr•DMS and i-PrMgCl was used, the reaction 
was complete within 0.5 h, whereas the t-BuMgBr derived cuprate yielded only modest 
conversion even when warmed to room temperature.  We were specifically excited about 
the aryl addition since this was the first example of an sp2 hybridized nucleophile adding 
successfully with such high yield. (entry 4).   
 
Table 16.  Cuprate additons to bicyclic β-lactone 2.17. 
O
O O
O
R1MgX, TMSCl
CuBr DMS,
DMS, THF,
-42oC -5oC
O
O
CO2R
2
R1
2.17 2.18a-d
entry R product compound no. % yield
1
2
3
4b
Me
i-Pr
t-Bu
Ph
O
O
CO2H
Me
O
O
CO2H
O
O
CO2H
O
O
CO2Me
Ph
2.18a
2.18b
2.18c
2.18d
62
56
25
72
 
aMajor contributions in this table and above section have been made by Dr. 
Wei Zhang.  bConditions used for aryl addition:  0.02 M, 5.55 equiv of 
cuprate, 11 equivs of 2.0M PhMgCl in THF, 16.0 equiv of DMS, TMSCl 
(1.5 equiv), -42 to 10 oC, 6-10 h. Choro-Grignard's must be used.  
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 2.  Application to Merck IND 
 Motivated by the success of the alkyl and aryl cuprate additions to the bicyclic β-
lactone, we wanted to attempt the addition of a meta-fluorophenyl adduct since this 
would be a precursor to the same intermediate previously synthesized by Merck, as 
discussed above.  To minimize the production of the bromo-acid by-product, an aryl 
cuprate derived from (3-fluorophenyl)magnesium chloride and CuCl were used for the 
addition to the dioxolane substituted bicyclic β-lactone 2.17.  Subsequent reduction via 
borane-THF complex (64% yield over 2 steps) followed by deprotection with 1N HCl 
afforded the desired ketone 2.9 in 95% yield (Scheme 2.5).   
 
Scheme 2.5 
(64%)
(2 steps)
(95%)(43% overall)
(92% ee)
FClMg
1)
CuCl, THF
2) BH3 THF,
THF, 0 oC
O
O O
3 steps
(ref. 30b) OO
O
O
OO
OH
F
2.172.20 2.21
1N HCl, THF
23oC, 16 h
OH
F
O
2.9
 
 
D.  Summary 
 Highly diastereoselective, Cu(I)-mediated additions to 2.17 with either alkyl or aryl 
cuprates proceeded with inversion of stereochemistry to provide access to trans-
substituted cyclopentanone acids.   By optimizing this methodology, we were able to 
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minimize the formation of the bromo-acid by-product and improve the yields of the alkyl 
and typically problematic aryl cuprates.  The applicability of this process was 
demonstrated by the short, efficient synthesis of a Merck IND intermediate in 6 steps as 
opposed to 9 steps (as previously reported).  The synthesis produced the cyclopentanone 
2.9 from ketone 2.20 in 26% overall yield. 
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CHAPTER III 
THE NUCLEOPHILE PROMOTED BIS-CYCLIZATION AS APPLIED 
TOWARDS DIONES, AMINO ACID DERIVATIVES AND OTHER α-
SUBSTITUTED KETO-ACIDS 
 
A. Background:  Keto-acids 
 β-lactones are strained four membered rings and offer synthetic chemists 
considerable flexibility as useful intermediates.32  The production of optically active β-
lactones began in 1982, when Wynberg utilized chiral catalysts to assist in a net [2+2] 
cycloaddition (aldol-lactonization) reaction between ketene and various activated 
carbonyl compounds.2  Wynberg found the use of diastereomeric cinchona alkaloids 
(quinidine and quinine) to be especially effective in obtaining high enantiomeric excess 
of β-lactones.4 (Chapter I).  We were able to build upon and optimize this methodology, 
which greatly increased the applicability of the nucleophile catalyzed aldol-lactonization 
(NCAL) towards the synthesis of bioactive natural products.    
 Recently, the scope was expanded by incorporating the use of keto-acids as 
substrates, which initially gave low yields due to the lower electrophilicity of ketones.  
However, we explored several tertiary amines and bases that might increase the 
nucleophilicity of the ammonium enolate thereby promoting the crucial aldol.  Such 
nucleophiles would need to have increased electron density on the heteroatom 
(nitrogen), and bases such as DMAP and PPY (Figure 5) were obvious choices.  To date, 
PPY has proven to be the best nucleophile and DIPEA remains as the best base.   
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N N
DMAP
(N,N-4-dimethylaminopyridine)
N N
PPY
(4-pyrrolidinopyridine)  
Figure 5.  Nucleophiles DMAP and PPY. 
 
            Generally, there are two possibilities for the formation of the lactone from keto-
acids:  a [2+2] pathway between a ketene and carbonyl or a nucleophile promoted 
pathway between an ammonium enolate and carbonyl. Our studies seem to favor a rate-
determining, nucleophile promoted process based on several factors (see Chapter I) 
specifically that more nucleophilic substances are more efficient.  In addition, the use of 
only Hunig's base produced no β-lactone and this suggests a nucleophile catalyzed 
process.21  Although we have not found evidence of ketenes via in situ IR spectroscopy, 
we cannot exclude the possibility of such a short lived intermediate.8  Also, as studies 
proceed, we will be able to gain further insight by using chiral nucleophiles and then 
confirming our hypothesis based on stereochemical induction of the derived β-lactones. 
Scheme 3.1 
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 Thus far, we have been able to take advantage of this process and efforts are 
currently underway to fully explore and investigate the limits of this methodology. Our 
group has been successful in establishing a set protocol for aldehyde-acids and keto-
acids separately.  Although we have investigated the aldehyde-acid substrates quite 
extensively in the past, several families of keto-acids remain unexplored.  Recently, we 
have been studying these keto-acid substrates and successfully prepared several 
examples which yield the desired β-lactones in moderate to high yields, with varying 
degrees of diastereoselectivity (Figure 6).21  
   
CO2HR1
O
R
N
Pr
Br
OTf
i-Pr2NEt, CH2Cl2,
PPY, 25°C
O
R
H
R1
O
O
O
Me
H
O
O
O
OH
Me
Ph
3.10 (75%)3.9 (78%)
O
O
CO2Et
3.11 (70%)
dr (~1:1) dr (>19:1)
3.7 3.8
 
Figure 6.  Examples of the NCAL with  keto-acids. 
 
 
 After such promising results, it has been a goal to find the limits of this process 
and fully investigate the diversity of substrates that can be utilized in the intramolecular 
NCAL process.  Specifically, we are interested in studying members of the keto-acid 
class such as diones, protected amino acids, tricyclics, heterocycles and derivatives.  We 
plan to test which ring sizes can be tolerated by this methodology and investigate the 
various functionalities that are compatible with the optimized reaction conditions.  This 
will potentially utilize this process in order to effectively and efficiently synthesize 
natural/unnatural products and/or their intermediates. 
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B.  Various Substrates Studied 
 1.  Tricyclic β-Lactones 
 Recently, our group has made several advances in the production of β-lactones in 
which we have placed different heteroatoms in and around the substrate as well as 
increasing the complexity of the keto-acid.  In terms of complexity, we decided to 
explore the realm of tricyclics and observe both the efficiency of reaction and 
conformation of these products.   
  a. 5- and 6-membered Diones 
 Our efforts towards testing our conditions on various keto-acids substrates begins 
with 2-methyl substituted 1,3-diones.  Five and six-membered diones are commercially 
available and stable at lower temperatures.  Initially, we envisioned a simple approach to 
directly append the ester side chain onto the dione 3.15a (Scheme 3.2).  Due to other 
studies in our group, O-alkylation was expected to occur and in order to minimize this 
propensity, a Finkelstein33 reaction was run on the bromo-ester to convert the halogen 
into an iodide.  This was done in hopes to make the electrophilic carbon more 'soft'.  
This should favor attack by the "softer" enolate carbon versus the 'hard' enolate 
oxygen.34  Several trials and reaction conditions were screened35 to append on the alkyl-
ester chain with little success.  Even though precautions were taken, the major product 
was O-alkylation in all cases with only trace amounts of the desired C-alkylation product 
3.16a. 
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Scheme 3.2 
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 In order to circumvent this O-alkylation problem, the procedure of Katoh36 was 
studied in which a similar side chain was provided in a two step process.  It was then 
decided to use allyl iodide and allyl bromide as electrophiles.  This has a two fold benefit 
in that allyl halides are not only known to be good electrophiles in enolate chemistry but 
even if O-alkylation were to occur, the Claisen rearrangement would result in the desired 
product, 3.20a. (Scheme 3.3).  Triton B was chosen as the base and MeOH as the 
solvent.37 
 
 
 
 
 39 
Scheme 3.3 
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 Next, we screened several metathesis catalysts and equivalents of substrate to 
find the optimal conditions for extending the chain with methyl acrylate.  Some 
homodimerization was observed with this allyl halide as expected,38 however it was 
isolated as a minor by-product and was not a major hindrance to the desired reaction 
pathway.  Grubb's 2nd Generation catalyst proved to be the most efficient, generating the 
desired α,β−unsaturated ester 3.16a in 69% overall yield (Table 17). 
 
 
 
 
 
 
 
 40 
Table 17.  Screening Grubbs' catalysts. 
3.20a
O
O
methyl acrolate,
5 mol% G1 or G2
DCM, 40 oC
O
O
O
OMe
3.16a  
entry acrolate (eq) G1 or G2 time (hrs) yield 
1 2 G1 8 4 % 
2 5 G1 26 trace 
3 2 G2 8 69 % 
 
 After reduction of the olefin, hydrolysis of the methyl ester 3.16a to the acid 
3.22a proved to be a difficult task.  Several conditions such as LiOH and NaOH were 
attempted without success so the corresponding benzyl acrylate was utilized and thus 
eliminated one step from the sequence. NCAL conditions were then applied to the keto-
acid, 3.22a and yielded the desired β-lactone, 3.19a as a single diastereomer.  The 
overall yield for this 6,5-system was quite high and so the product, 3.19a lent itself as an 
attractive starting material for other investigations.  This  being the case, more material 
had to be prepared and the entire sequence scaled up.  The final procedural modification 
was to use ozonolysis to convert the olefin to the aldehyde and then directly quenching 
with 1.3 equivalents of ylide,39 (commercially available) which proved to be a 
convenient method to avoid the use of Grubbs 2nd Generation catalyst on large scale 
(Scheme 3.4).  The success of this encouraged us to try a variety of dione ring sizes.  
Next, we focused on 2-methyl-1,3-cyclopenadione 3.15b and we followed the exact 
same route as previously described and obtained comparable yields of β-lactone 3.19b.  
The NCAL was also attempted on the 6-membered dione, 3.22a using conditions found 
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for aldehyde acids (i.e. modified Mukaiyama's reagent and acetonitrile as solvent) and 
although the desired β-lactone was isolated, it was in reduced yield (70%).    
Scheme 3.4 
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 Previous cyclizations with carbocycle keto-acids have not been as efficient and 
so we speculate as to why these diones readily cyclize.  From our experience, there seem 
to be two possibilites.  Diones are unique since they contain two carbonyls and statistics 
would dictate that chances of reaction are higher.  Secondly, compared to similar 
compounds, previously synthesized in our group, the only difference is conformation.  
The second carbonyl makes the system more rigid keeping the acid and ketone closer in 
space, thus decreasing entropy and increasing reactivity, as dictated by the Thorpe-
Ingold effect.  We propose this would be kinetically favored, especially for the formation 
of 5 and 6-membered rings.   
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  b. 7- and 8-membered Diones 
 To further investigate the scope of this methodology, we decided to explore the 
corresponding 7 and 8-membered methyl diones.  Although not commercially available, 
precedents in the literature40 allowed us to pursue further studies on these substrates.  
The procedures were followed as they were described with minor modifications in order 
to form the 7 and 8-membered diones and then the previous route applied to obtain the 
β-lactones.  Major differences included higher yields when allylating and reduced yields 
for β-lactones 3.19c and 3.19d.  Both acids, 3.22c and 3.22d produced two 
diastereomers with a 1:4 ratio for the 7,5 system, 3.19c and a 1:3.7 ratio∗ for the 8,5 
system, 3.19d (Scheme 3.5).   
 One possible explanation for the reduced yields is that the conformation prior to 
cyclization is not as conducive and does not have the reactive groups in such favorable 
proximity.  This would support our previous hypothesis on conformational benefit for 
other dione systems.  
 
 
 
 
 
 
 
                                                 
∗ diastereomeric ratios determined by crude 1H-NMR. 
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  c. Other Diones 
 Since we had explored several diones with varying sizes of their stationary ring, 
we wanted to investigate cyclizing other ring sizes.  It was previously found by a 
colleague in our group∗ that formation of a 6 membered ring during the NCAL protocol 
yielded only low conversion.  This was concluded after his completion of a 6,6 dione 
ring system, 3.30 with only a 38% yield (Figure 7).   
O
Me
O
O
3.30  
Figure 7.  Tricyclic β-lactone 3.30. 
 
  Nonetheless, we attempted to construct tricyclic β-lactone 3.34 from 2-methyl-
1,3-dione 3.15b (Scheme 3.6).  Alkylation with acrolein, according to a procedure by 
Huddleston41 delivered 3.31.  The aldehyde was then converted to the benzyl ester 3.32, 
which after hydrogenation gave the acid 3.33.  The keto-acid was then subjected to our 
typical NCAL conditions which yielded the desired β-lactone 3.34 in 55% yield. 
 
 
 
 
                                                 
∗ Thanks to Vikram Purohit for the synthesis of the 6,6-β-lactone (3.30). 
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Scheme 3.6 
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 We also envisioned the synthesis of a 6,7 system.  Although the cyclization of 7 
membered rings is known to be less favorable than 5 or 6, we reasoned that the lower 
strain energy (H = 7.6 kcal/mol) and entropy (S = 19 carbon/degrees) of 7 membered 
cyclic systems (as compared to 8,9,10 & 11) was favorable enough to yield our desired 
product in reasonable yields.42  Following our previous studies, acid 3.37 was prepared 
however, upon cyclization no β-lactone 3.38 was found (Scheme 3.7).  With these 
findings, the boundaries of dione cyclizations become more defined. 
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Scheme 3.7 
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 In addition to our NCAL protocol for the synthesis of tricyclic β-lactones, recent 
publications have shown N-heterocyclic carbenes being used as catalysts to synthesize 
both β- and γ-lactones.15,17 We wanted to explore the possibility of synthesizing our 
substrates via this method, which led us to study the IMes•HCl catalyst for achieving 
such transformations.  Although the products were isolated in reduced yields, the use of 
NHC's as a methodology has great potential for the optically active synthesis of lactones. 
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Scheme 3.8 
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 2.  Bicyclic β-Lactones 
 Motivated by our success with the diones and formation of tricyclic β-lactones, we 
wanted to explore the synthesis of bicyclic β-lactones.  Since we have had much success 
with these substrates in the past and have studied them extensively, we wanted to delve 
into such constructions with heteroatoms as substituents on the main bicyclic moiety.  
Although our results were not as exciting as those of the diones, we were able to learn 
from their failures and set one more boundary in this previously unexplored territory.    
  a. α-Amino Substituted 
 We began our investigation into the heteroatomic bicyclic β-lactones with an 
amino acid inspired substrate.  Although the synthesis of the acid substrate was quite 
time consuming and its completion was rewarding enough, the key transformation (the 
NCAL) was unsuccessful (Scheme 3.8).  We began the route by making a diphenyl 
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ketimine 3.40 and protecting the benzylated glycine amino acid, based on the precedent 
of Pickard and O'Donnell.43  Once the protected amino acid 3.41 was made, we screened 
several methods in order to alkylate including phase transfer conditions44 and lithium 
bases,45 but finally KOtBu45 gave the best result yielding 3.42.  The next step was to 
remove the imide group which was unexpectedly challenging.  However after several 
methods such as 15% citric acid,46 aqueous HCl18b,47 and finally with hydroxylamine 
hydrochloride (NH2OH•HCl)
48 the desired deprotection was successful.  After the free 
amine 3.43 was in hand, it was protected with tosyl chloride to give ester 3.44.  Wacker 
oxidation would presumably deliver the methyl ketone 3.45 and as such, several 
conditions were tried with the final method utilizing PdCl2 in an oxygen atmosphere; the 
desired ketone 3.4549 was isolated.  After successful isolation of the Wacker product, the 
benzyl ester was deprotected via hydrogenation followed directly by the NCAL.  Due to 
the insolubility of the acid 3.46 in methylene chloride, the keto-acid was added in 
acetonitrile however, no desired β-lactone was isolated. Decomposition of the acid 3.46 
was observed presumably because of the acidic amine hydrogen competing with the 
acid. 
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Scheme 3.9 
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  b.  Miscellaneous 
 In conjunction with the previous effort, we then decided to pursue a different 
type of bicyclic β-lactone.  Our initial idea was to test whether a dione could be prepared 
without a methyl group.  Since efforts towards preparing an acid from the corresponding 
non-methyl substituted dione were unsuccessful, we decided to try a thiophenyl group in 
place of the methyl. 
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Scheme 3.10 
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 Current studies are underway towards the preparation of this substrate, however 
initial results are not promising.  Preliminary trials have been attempted in order to 
allylate, however under various conditions such as Triton B in MeOH and LHMDS in 
THF, only unidentified by-products have been formed. 
 Another possible target has evolved from our unsuccessful phenyl adduct.  A 
para-nitrophenyl substituent is presumed to yield a productive aldol-lactonization due to 
its electron withdrawing properties.  Initial studies have begun towards the substrate, 
however the Grignard step towards the acid 3.57 has thus far been quite difficult to 
initiate.  The Grignard reaction was attempted both in ether and THF with activated 
magnesium turnings.  Initiators such as iodine, dibromoethane and heat were used with 
no success.  Further studies will be necessary to complete the desired substrate.  
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Scheme 3.11 
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C.  Summary 
 In an effort to expand the repertoire of substrates available to the nucleophile 
promoted aldol-lactonization, we explored several acids with varying functionality, 
structure and substituents.  The already established protocol for keto-acids was applied 
toward diones of varying cyclic sizes and high to moderate yields were obtained with 
high to moderate diastereoselectivity (Table 18).  In general, most diones have proven 
themselves as excellent substrates towards biscyclization via the NCAL .  Overall, we 
are very pleased with the results of these studies and hope to further increase the scope 
of the NCAL procedure with keto-acids. 
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Table 18.  Tricyclic β-lactones synthesized from diones. 
β-lactone yield dr
a 
O
OMe
O
 
93 >19:1 
OMe
O
O  
80 >19:1 
O
Me
O
O 7
 
82 4:1 
O
Me
O
O
8
 
44 3.7:1 
O
Me
O
O
 
38 >19:1 
O
O
O
 
55 >19:1 
a Diastereomeric ratios determined by 1H-NMR of crude product mixtures.  Minor diastereomer not 
observed for values >19:1. 
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CHAPTER IV 
TRICHLORO β-LACTONES AS SUBSTRATES FOR TRICHLOROLEUCINE 
AND TRICHLOROBUTANOIC ACID 
 
A. Trichloro β-Lactones:  Cleavage of the Alkyl C-O Bond 
 Far from NCAL cyclizations, one of our long term goals involved finding 
specific conditions for β-lactone 4.1 opening to form (S)-trichloromethyl butanoic acid 
4.2.  We wanted to study two distinct approaches:  the first was via methylcuprate 
addition (see chapter II) and the second was via hydride addition.  Our interest in β-
lactone alkyl C-O bond cleavage is rooted in the fact that β-lactones are extremely useful 
and versatile intermediates which provide access to several natural and unnatural 
products (Figure 8).  Specifically, the tri-chloro β-lactone 4.2 when opened, leads to a 
particularly useful moiety. 
 
O
O
Cl3C
Cl3C OH
Me O
Ph
N
Me
OMe
Me
CCl3O
N S
N
Me
Me
O
HO
CCl3
O
CCl3
Cl3C
Me OMe
O
O
OMe
4.1 4.2
4.3 4.4 4.5  
Figure 8.  Trichloro β-lactone in natural products. 
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 Our initial goal was to find the best method to open (R)-4-(Trichloromethyl-2-
oxetanone 4.1.  Once we established the most efficient way, we could then apply it to 
acyl bond cleavage of (R)-methyl-trichloromethyl β-lactone 4.6 towards the synthesis of 
(S,S)-trichloroleucine 4.11.  Our route would be highlighted by addition of the enolate of 
α-diazoethyl acetate, 4.7, followed by thermolysis followed by decarboxylation of the 
(R)-methyl-trichloromethyl β-lactone.  The γ-lactone 4.9 will then be subjected to α-
azidation with trisyl azide which should give us the correct stereochemistry for 4.10.  
Ethanolysis then deoxygenation and hydrolysis followed by azide reduction should 
provide trichloroleucine (Scheme 4.1). 
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B. Methods 
 1. Methylcuprate Additions 
 First, we began efforts towards cleavage of the alkyl C-O bond via methylcuprate 
addition to the β-lactone 4.2.  Unfortunately results in our laboratory have shown that 
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this leads to the elimination product, as documented by Ashby.50  We attempted this 
reaction using both TMSCl as the Lewis acid and the stronger TIPSOTf at colder 
temperatures in order to create a more electron deficient environment at the β-carbon on 
4.1.  In both cases, the same elimination product was isolated as the major product.  We 
presume a single electron transfer mechanism is operative, thus leading to the undesired 
by-product (Scheme 4.2). 
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 In addition, we wanted to try the same methylcuprate addition onto the 4-
dichloromethyl-2-oxetanone.  We reasoned that having one less chlorine atom would 
make a less stable radical, thus hindering the single electron transfer cascade.  As such, it 
did provide the desired product, however only in trace amounts∗.  On the other hand, no 
olefin was visible by 1H-NMR. 
                                                 
∗ Preliminary studies indicate the successful synthesis of this product, however it has not been confirmed. 
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 2.  Hydride Additions 
 Since the methylcuprate pathway does not open the trichloro β-lactone in the 
desired fashion, we decided to try a hydride addition.  Although stereochemistry would 
be lost in such an addition, we wanted to confirm the feasibility of the reaction in 
general.  We thus used triethylsilane as the hydride source and TIPSOTf as the Lewis 
acid,51 however after 5 hours and slowly warming from -78 oC to 0 oC, no change was 
observed by TLC and only starting material was isolated (Scheme 4.3).  Another 
possibility would be to use Stryker's reagent [Ph3P(CuH)]6 since it has been shown to 
chemoselectively reduce lactones52. 
 
Scheme 4.3 
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C. Summary 
 Cuprate additions to β-lactones continue to be highly useful due to the potential 
versatility of products that can be obtained.  However, cuprate additons have historically 
been quite sensitive to varying reactions conditions and as such our studies in this area 
are not over.  Although our initial studies with methyl cuprate addition to the trichloro β-
lactone have not been successful, intriguing results with the dichloro β-lactone have 
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been obtained and one can speculate that altering some conditions combined with further 
studies may lead to isolation of the desired acid 4.2.     
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CHAPTER V 
CONCLUSION 
 
 Recent years in our laboratory have yielded an expansion of substrates that are 
susceptible to the NCAL.  Aldehyde and keto-acids can broad and diverse compounds 
and as such can lend the same attractive attributes to their respective β-lactone product.  
Providing chemists with a wide array of interchangeable functionality which can still be 
applicable to the same NCAL protocol is invaluable as a useful methodology.  In 
addition, the β-lactone has also served as a useful intermediate towards natural product 
synthesis and exploring the methods in which to open it efficiently can also serve as a 
highly desirable and applicable reaction.  Because of this importance, we have been 
engaged in both the synthesis and manipulation of this functionality. 
 We have investigated several types of substrates such as diones, large cycles, 
amino acid derivatives as well as simple, straight chain acids with varying functionality 
α to the ketone.  We then discovered that the greater electrophilicity of the diones has 
produced high yields and good diastereoselectivity when subjected towards NCAL 
conditions.  The diones, together with the other types of substrates have greatly 
improved our view into NCAL bis-cyclizations and gave us a basic idea of which 
substrate features are advantageous when applying this methodology.     
 In addition to studies towards the formation of β-lactones, we have also 
investigated cuprate additions to them.  Due to the dual reactivity of β-lactones, cuprates 
have been found to afford soft nucleophilic addition to the b-carbon yielding cleavage of 
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the acyl C-O bond.  We have exploited this fact and have successfully achieved 
stereochemical invertive ring cleavage of bicyclic b-lactones which lead 
stereospecifically to b-substituted cyclopentyl and cyclohexyl carboxylic acids.  
Specifically, we have been able to apply this method to the synthesis of an 
investigational new drug (IND) intermeidate initially synthesized by scientists at Merck.  
In addition, we have applied this to the synthesis of several acids.  Studies are currently 
underway in our laboratory to further explore these versatile cuprate additions to 
polychlorinated β-lactones. 
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CHAPTER VI 
EXPERIMENTAL PROCEDURES 
 
General 
 All non-aqueous reactions were carried out with flame dried glassware and          
under a nitrogen atmosphere.  Tetrahydrofuran (THF), methylene chloride (DCM), 
dimethylformamide (DMF) and toluene were dried and purified by a MBRAUN solvent 
purification system by passage under 8 psi N2 through activated molecular sieves.  
Methanol (MeOH) was distilled from magnesium prior to use.  Trimethylsilyl chloride 
(TMSCl), triethylamine (TEA), Hunig's base (diisopropylethylamine) and benzene were 
distilled from calcium hydride prior to use.  All other solvents and commercially 
available reagents were used as received.  Brine refers to a saturated solution of sodium 
chloride.  Reactions were followed by thin layer chromotography (TLC) on SiliCycle® 
silica gel 60 Å F254 (250 µm).  Visualization of the developed plate was accomplished by 
fluorescence quenching and by staining with potassium permanganate (KMnO4).  
Chromatographic purification of compounds was accomplished by flash chromatography 
on SiliCycle® SiliaFlash® F60, 40-63 µm 60 Å.  
 Nuclear magnetic resonance (NMR) spectra were acquired on a Varian Inova-
500 MHz operating at 500 and 125 MHz for 1H and 13C, respectively and are referenced 
internally according to residual solvent signals.  1H NMR coupling constants (J) are 
reported in Hertz (Hz) and multiplicity is abbreviated as follows:  s = singlet, bs = broad 
singlet, d = doublet, dd = doublet of doublets, ddd = doublet of doublets of doublets, 
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dddd = doublet of doublets of doublets of doublets, t = triplet, dt = doublet of triplets, td 
= triplet of doublets, m = multiplet.  IR spectra were acquired using a Bruker Tensor 27 
FTIR spectrophotometer.  Vibration frequencies are expressed in cm-1.  Mass spectra 
were obtained at the Laboratory for Biological Mass Spectrometry (LBMS) at Texas 
A&M University.  Melting point data was acquired on a Stanford Research Systems EZ-
Melt, automated melting point apparatus.  Temperatures are expressed in degrees 
Celsius.  
 
Procedures 
Representative Procedure for the Preparation of β-lactones via the NCAL protocol 
as described for 3.19a-d: 
 
O
O
O
OHn
3.22a-d
N
Pr
Br
OTf
i-Pr2NEt, CH2Cl2,
PPY, 25°C
O
O
O
n
3.19a-d  
Tricyclic β-lactone 3.19a;(n = 2): 
 PPY (66.25 mg, 0.447 mmol, 1.5 equiv) and modified Mukiyama's 
Reagent2 (156.52 mg, 0.447 mmol, 1.5 equiv) were weighed out in a dry 25 
ml round bottom flask and diluted with 3.5 mL DCM (0.05 M) resulting in a 
white slurry.  Hunig's base (0.13 mL, 0.745 mmol, 2.5 equiv) was then 
                                                 
2 Oh, S. H.; Cortez, G. S.; Romo, D. J. Org. Chem. 2005, 70, 2835. 
O
O
O
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added followed by slow addition of the keto-acid 3.22a (63.2 mg, 0.298 mmol, 1 equiv) 
in 2 mL DCM over 1 hour via a syringe pump.  After the addition of keto-acid 3.22a was 
complete, the resulting clear, bright orange solution was stirred for an additional 12 h at 
21 oC.  The mixture was then concentrated in vacuo, re-dissolved in EtOAc and 
quenched with saturated NH4Cl solution. The organics were extracted with EtOAc (x3), 
washed with sat. NH4Cl sol. (x3) and brine (x1), dried over MgSO4, filtered and 
concentrated.  The crude product was purified via flash column chromatography with 
SiO2 (0-10-20-30% EtOAc/Hex) to yield β-lactone, 3.19a (78.5 mg, 95%) as a white 
solid.  mp:  64.9-65.3 oC (recrystallized from EtOAc);  IR (thin film): 1826 cm-1, 1711 
cm-1; 1H NMR (500 MHz, CDCl3) δ 3.47-3.46 (dd, J = 1, 7, 1H), 2.75-2.71 (m, 1H), 
2.57-2.50 (dt, J = 5.5, 14.5, 1H), 2.37-2.31 (dd, J = 4, 14.5, 2H), 2.26-2.22 (td, J = 3, 7.5, 
1H), 2.11-2.07 (m, 1H), 1.95-1.91 (dd, J = 5.5, 12.5, 1H), 1.61-1.48 (m, 2H), 1.44-1.36 
(m, 1H), 1.27 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 210.45, 170.73, 89.68, 59.27, 
58.97, 37.38, 32.14, 28.26, 24.82, 19.73, 18.55;  LRMS (CI) Calcd for C11H14O3 [M+H]: 
195.  Found: 195. 
Tricyclic β-lactone 3.19b;(n = 1): 
 The acid precusor, 3.22b (123.5 mg, 0.623 mmol) was subjected to 
the conditions above and upon purfication with flash column 
chromotography (0-10-20-30-40% EtOAc/Hex) to yield β-lactone 3.19b 
(95.2 mg, 85%) as a white solid.  mp:  123.9 - 124.8 oC (recrystallized from EtOAc);  IR 
(thin film): 1821 cm-1, 1735 cm-1; 1H NMR (500 MHz, CDCl3) δ 3.68 (d, J = 8, 1H), 
2.73-2.67 (ddd, J = 2.5, 9, 19.5, 1H), 2.54-2.45 (m, 2H), 2.39-2.35 (dd, J = 7, 13.5, 1H), 
O
O
O
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2.23-2.16 (m, 1H), 2.03-1.99 (dd, J = 7.5, 13, 1H), 1.77-1.71 (dt, J = 7.5, 13.5, 1H), 
1.52-1.43 (m, 1H), 1.09 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 216.52, 170.03, 91.87, 
61.02, 56.97, 36.79, 34.20, 25.57, 24.74, 15.83; LRMS (CI) Calcd for C10H12O3 [M+H]: 
181. Found: 181. 
Tricyclic β-lactone 3.19c;(n = 3): 
 The acid precursor, 3.22c (531.8 mg, 2.35 
mmol) was subjected to the representative 
procedure for the formation of β-lactones and the 
crude product was purified via flash column 
chromatography on SiO2 (10-20-30-40% EtOAc/Hex) and the pure syn and anti 
diasteromers were isolated as well as a mix ( syn: 335 mg, 68%, anti: 40.3 mg, 8%, mix: 
71.6 mg, 18%, total: 91%) as solids.  syn: IR (thin film): 1824 cm-1, 1699 cm-1; 1H NMR 
(500 MHz, CDCl3) δ 3.64 (d, J = 8, 1H), 2.90-2.85 (m, 1H), 2.37-2.27 (m, 2H), 2.22-
2.12 (m, 2H), 2.09-2.05 (dd, J = 7.5, 14, 1H), 2.02-1.89 (m, 2H), 1.87-1.82 (m, 1H), 
1.81-1.75 (m, 1H), 1.67-1.58 (m, 1H), 1.45-1.34 (m, 1H), 1.34 (s, 3H);  13C NMR (125 
MHz, CDCl3) δ 212.11, 171.45, 91.13, 60.39, 59.10, 40.59, 36.44, 31.93, 25.57, 24.90, 
23.89, 19.06;  LRMS (APCI) Cacld for C12H16O3 [M+H]:  209.  Found:  209.  anti:  IR 
(thin film):  1824 cm-1, 1693 cm-1; 1H NMR (500 MHz, CDCl3) δ 3.55-3.53 (td, J = 0.5, 
8, 1H), 2.73-2.67 (ddd, J = 1.5, 6, 17.5, 1H), 2.61-2.54 (ddd, J = 2.5, 12, 17, 1H), 2.27-
2.20 (m, 3H), 2.01-1.95 (m, 3H), 1.93-1.79 (m, 4H), 1.24 (s, 3H);  13C NMR (125 MHz, 
CDCl3) δ 212.50, 171.14, 89.89, 61.76, 59.51, 44.67, 35.36, 31.55, 25.50, 23.23, 22.72, 
22.02;  LRMS (APCI) Cacld for C12H16O3 [M+H]:  209.  Found:  209.  
O
O
O
(syn)-3.19c O
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Tricyclic β-lactone 3.19d;(n = 4): 
 The keto-acid precursor 3.22d (197.9 mg, 
0.82 mmol) was subjected to the conditions and 
protocol outlined in the representative procedure for 
the formation of β-lactones.  The crude product was 
purified via flash column chromatography with (20-30-40% EtOAc/Hex) to yield pure 
syn and anti diastereomers 3.19d as solids. (syn: 77 mg, 42%, anti: 4.1 mg, 2%, total: 
44%).  syn:  mp:  94.2 oC (recrystallized from benzene);  IR (thin film):  1821 cm-1, 1696 
cm-1; 1H NMR (500 MHz, CDCl3) δ 3.46 (d, J = 7.5, 1H), 2.98-2.92 (m, 1H), 2.50-2.46 
(dd, J = 6.5, 13, 1H), 2.46-2.25 (m, 2H), 2.18-2.13 (m, 1H), 2.12-2.05 (m, 1H), 2.03-
1.98 (m, 1H), 1.96-1.88 (m, 1H), 1.67-1.56 (m, 2H), 1.40-1.34 (m, 1H), 1.38 (s, 3H), 
0.79-0.38 (m, 1H);  13C NMR (125 MHz, CDCl3) δ 214.12, 171.59, 91.98, 59.41, 59.05, 
37.86, 35.39, 31.85, 28.72, 27.85, 26.19, 22.59, 18.52;  LRMS (CI) Cacld for C13H18O3 
[M+H]:  223.  Found:  223.  anti:  IR (thin film):  1824 cm-1, 1693 cm-1; 1H NMR (500 
MHz, CDCl3) δ 3.55-3.53 (d, J = 9.5, 1H), 3.63-3.33 (td, J = 3.75, 11, 1H), 2.27-2.2 (m, 
2H), 2.18-2.09 (t, J = 31.5, 2H), 2.07-2.01(m, 2H), 1.89-1.81 (m, 2H), 1.76-1.69 (m, 
2H), 1.61-1.55 (m, 2H), 1.46-1.41 (m, 1H), 1.15 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 
216.43, 171.07, 92.63, 61.52, 56.91, 38.72, 35.65, 32.95, 30.34, 24.74, 24.17, 23.90, 
19.21;  LRMS (CI) Cacld for C13H18O3 [M+H]:  223.  Found:  223. 
 
 
 
O(syn)-3.19d (ant i)-3.19d
O
O
O
O
O
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Tricyclic β-lactone 3.34: 
 The corresponding precursor acid 3.33 (400 mg, 1.89 mmol) was 
subjected to the conditions outlined in the representative procedure for the 
NCAL.  The crude product was purified via flash column chromatography 
(20-30-40% EtOAc/Hex) to yield β-lactone 3.34 (228 mg, 62%) as a 
yellow, viscous oil.  IR (thin film):  1832 cm-1, 1741 cm-1;  1H NMR (500 MHz, CDCl3) 
δ 3.50-3.47 (dd, J = 6.5, 15.5, 1H), 2.64-2.50 (m, 2H), 2.26-2.15 (m, 2H), 1.86-1.79 (m, 
3H), 1.57-1.55 (m, 1H), 1.43-1.38 (ddd, J = 10, 3, 13, 1H), 1.15-1.06 (m, 1H), 1.08 (m, 
3H);  13C NMR (125 MHz, CDCl3) δ 217.49, 171.27, 83.64, 52.56, 49.98, 36.17, 31.60, 
30.61, 22.40, 20.40, 19.19; LRMS (APCI) Cacld for C11H14O3 [M+H]:  195.  Found:  
195. 
Representative Procedure for the allylation of the 7 and 8 membered diones and 
1,3-cyclohexanedione as described for 3.20c/d: 
O
O
O
O
Br
Triton B
MeOH,
,
n n
3.15c/d 3.20c/d  
Allyl dione 3.20c; (n = 1): 
 The 2-methyl-1,3-cycloheptandione 3.15c was prepared according to the 
procedure outlined by Lewicka-Piekut.3  The dione (339.6 mg, 2.42 mmol, 1 equiv) in a 
15 mL seal tube was diluted with 3.4 mL freshly distilled MeOH to form a brown slurry.  
                                                 
3 (a) Lewicka-Piekut, S.; Okamura, W.H. Synth. Comm., 1980, 10, 415.  (b) Brooks, D.W.; Mazdiyasni, 
H.; Sallay, P. J. Org. Chem. 1985, 50, 3411.  (c) Letsinger, R.L.; Kammeyer, C.W. J. Am. Chem. Soc. 
1951, 73, 4476. 
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Upon addition of Triton B (1.03 mL, 2.42 mmol, 40% in MeOH) the dione dissolved to 
result in a clear brown solution.  The allyl bromide (0.23 mL, 2.67 mmol, 1.1 equiv) was 
added at 23 oC and then the mixture was heated to reflux (60oC) and stirred for 8 h.  
After cooling, 1M HCl was added to the mixture and allowed to stir vigorously for 10 
minutes.  The organics were extracted with EtOAc (x3) and washed with brine (x2).  
Dried over MgSO4, filtered and concentrated.  The crude product was purified via flash 
column chromatography with SiO2 (30-40-50% EtOAc/Hex) to yield the allylated 
product 3.20c (312 mg, 71%).  IR (thin film):  2940 cm-1, 1697 cm-1;  1H NMR (500 
MHz, CDCl3) δ 5.55-5.50 (m, 1H), 4.99-4.96 (m, 2H), 2.47-2.45 (dd, J = 7.5, 2H), 2.44-
2.36 (m, 4H), 1.84-1.81 (dddd, J = 3.5, 3.5, 3.5, 3.5, 4H), 1.14 (s, 3H);  13C NMR (125 
MHz, CDCl3) δ 212.37, 132.63, 119.03, 64.88, 41.66, 38.70, 28.15, 18.58; LRMS (CI) 
Calcd for C11H16O2 [M+H]:  181.  Found:  181. 
Allyl dione 3.20d;(n = 2): 
 The 2-methyl-1,3-cyclooctandione 3.15d was prepared according the Lewicka-
Piekut3 procedure and then used in the representative procedure outlined above (1.58 g, 
10.25 mmol) and the crude product was purified via flash column chromatography on 
SiO2 (10-20-30% EtOAc/Hex) and the pure allylated dione 3.20d (1.39 g, 70%) was 
isolated as a yellow oil.  IR (thin film):  2935 cm-1, 1692 cm-1;  1H NMR (500 MHz, 
CDCl3) δ 5.47-5.42 (m, 1H), 4.97-4.92 (m, 1H), 2.42 (d, J = 7.5), 2.34-2.31 (ddd, J = 6, 
1.5, 6, 4H), 1.62-1.57 (m, 4H), 1.47-1.45 (m, 2H), 1.12 (s, 3H);  13C NMR (125 MHz, 
CDCl3) δ 210.77, 132.74, 119.09, 65.08, 41.49, 38.57, 27.34, 25.18, 18.51;  LRMS (CI) 
Calcd for C12H18O2 [M+H]:  195.  Found:  195. 
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Allyl dione 3.60: 
O
O
O
O
Br
Triton B
MeOH,
,
3.59 3.60
O
OH
 
 The allylated dione 3.60 was prepared following the representative procedure 
above using 3.59 (1 g, 8.90 mmol).  The crude product was purified via flash column 
chromatography on SiO2 (30-40-50-60-70% EtOAc/Hex) to yield 3.60 (417 mg, 31%) as 
white solid.  IR (thin film):  3350-2200 cm-1 (broad), 1600 cm-1, 1550 cm-1;  1H NMR 
(500 MHz, CDCl3) δ 10.31-10.13 (bs, 1H), 5.82-5.76 (m, 1H), 5.00-4.96 (dddd, J = 1.5, 
1.5, 1.5, 17, 1H), 4.90-4.87 (dddd, J = 1.5, 1.5, 1.5, 10, 1H), 3.04 (d, J = 6.5, 2H), 2.46 
(t, J = 6.5, 4H), 2.42-2.33 (dt, J = 6, 32.5, 1H) (partially keto-form), 1.98-1.92 (m, 2H); 
13C NMR (125 MHz, CDCl3) δ 201.90, 136.90, 114.55, 114.21, 102.43, 102.37, 56.37 
(keto-form), 36.88 (keto-form), 33.33, 29.34 (keto-form), 26.50, 21.57 (keto-form), 
21.26;  LRMS (APCI) Calcd for C9H12O2 [M+H]:  153.  Found:  153. 
Representative Procedure for the benzyl ester of the 7 and 8 membered diones: 
O
O
O
O
n n
3.20c/d 3.21c/d
O
OBn
O3, DCM
Ph3PCHCO2Bn
 
Benzyl ester 3.21c;(n = 1): 
 In a 50 mL RBF, the SM 3.20c was weighed out (301.6 mg, 1.67 mmol, 1 equiv.) 
and dissolved in 10 mL DCM.  The solution was allowed to cool to -78oC and then 
ozone was bubbled in through a gas dispersion tube until the solution remained a cloudy 
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blue.  This was then followed by bubbling N2 until the solution returned to a clear light 
yellow again.  The ylide (893.4 mg, 2.18 mmol, 1.3 equiv.) in 5 mL DCM was added 
and the solution was allowed to stir overnight (~12 h) while warming slowly to rt.  The 
mixture was then concentrated in vacuo and purified via flash column chromatography 
on SiO2 (0-3-10% EtOAc/DCM) and the pure ester was isolated (158 mg, 30%).  IR 
(thin film):  2946 cm-1, 1720 cm-1, 1691 cm-1, 1655 cm-1;  1H NMR (500 MHz, CDCl3) δ 
7.29-7.26 (d, J = 4, 4H), 7.25-7.22 (dd, J = 4.5, 9, 1H), 6.72-6.69 (dddd, J = 8, 8, 8, 8, 
1H), 5.79 (d, J = 16, 1H), 5.21 (s, 2H), 2.56-2.54 (dd, J = 1, 7.5, 2H), 2.39-2.35 (m, 4H), 
1.82-1.78 (m, 4H), 1.15 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 211.41, 165.60, 143.44, 
136.03, 128.69, 128.36, 128.36, 124.76, 66.32, 34.45, 41.41, 36.78, 28.02, 18.62;  
LRMS (CI) Calcd for C19H22O4 [M+H]:  315.  Found:  315. 
Benzyl ester 3.21d;(n = 2): 
 The starting allylated dione 3.20d (1.39 g, 7.16 mmol)  was subjected to the 
representative procedure for obtaining the benzyl ester and the crude product 3.21d was 
purified via flash column chromatography on SiO2 (0-5% EtOAc/DCM) and the pure 
ester (821.8 mg, 35%) was isolated as a yellow oil.  IR (thin film):  2940 cm-1, 1697 cm-
1;  1H NMR (500 MHz, CDCl3) δ 7.36-7.32 (m, 5H), 6.79-6.76 (ddd, J = 8, 8, 15.5, 1H), 
5.93-5.89 (td, J = 1.5, 15.5, 1H), 5.15 (s, 2H), 2.69-2.67 (dd, J = 1, 7.5, 2H), 2.48-2.43 
(m, 4H), 1.73-1.70 (dddd, J = 5, 5, 5, 5, 4H), 1.59-1.58 (m, 2H), 1.30 (s, 3H);  13C NMR 
(125 MHz, CDCl3) δ 210.14, 165.83, 143.75, 136.17, 128.89, 128.62, 128.58, 125.07, 
66.59, 64.96, 41.40, 37.05, 27.33, 25.42, 18.67;  LRMS (CI) Calcd for C20H24O4 [M+H]:  
329.  Found:  329.  
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Representative Procedure for the preparation of keto-acid substrates: 
 
1) allyl bromide,
Triton B, MeOH,
2) O3, DCM,
Ph3PCHCO2Bn
3) H2, Pd/C
O
O
n
O
O
O
OHn
3.15a/b 3.22a/b  
 
Keto-acid 3.22a; (n = 2):   
 The 2-methyl-1,3-cyclohexanedione 3.15a (5.39g, 42.73 mmol, 1.0 equiv) was 
diluted with 54 mL of freshly distilled MeOH to create a turbid mixture.  Upon addition 
of 18.2 mL Triton B (40% in MeOH), the solution becomes a clear brown and then allyl 
bromide ( 4.04 mL, 47 mmol, 1.1 equiv) is added.  The solution was then heated to a 
gentle reflux (65-70oC) and allowed to stir for 12 h.  After cooling, 1M HCl solution was 
poured into the reactions flask and allowed to stir for 10-15 minutes.  The product was 
extracted with ethyl acetate (x3), washed with brine (x2), dried over MgSO4, filtered and 
concentrated.  The crude mixture was purified by flash column chromatography on SiO2 
(20-30% EtOAc/Hex) to yield the allylated dione, 3.20a4 (3.32 g, 47%) as a pale yellow 
oil.   
 The allylated dione, 3.20a (500mg, 3.3mmol, 1.0 equiv) was then dissolved in 17 
mL of DCM.  This was then cooled to -78oC and allowed to stir at this temperature for 
15 minutes.  Ozone was then bubbled through the solution through a gas dispersion tube 
until the mixture was blue.  Nitrogen was then bubbled through until the mixture 
returned to a clear white color.  The ylide (1.76 g, 4.3 mmol, 1.3 equiv) in 8.5 mL DCM 
                                                 
4 (a) Katoh, T.; Mizumoto, S.; Fudesaka, M.; Takeo, M.; Kajimoto, T.; Node, M. Tetradedron:  
Asymmetry 2006, 17, 1655. (b) Mori, K.; Fujiwhara, M. Tetrahedron, 1988, 44, 343. 
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was added to the mixture slowly, still at -78oC.  The mixture was then allowed to stir 
overnight 16 h while warming to 21oC.  The solvent was removed in vacuo and purified 
directly by flash column chromatography on SiO2 (25-35-50% EtOAc/Hex) to yield the 
α,β-unsaturated benzyl ester, 3.21a5 (433 mg, 44%) as a yellow oil.     
 The benzyl ester (1.74 g, 5.80 mmol) was then hydrogenated to yield the keto-
acid 3.22a (910.8 mg, 74%) as a white solid:  IR (thin film) 3530-2650 cm-1; 1726 cm-1; 
1693 cm-1; 1H NMR (500 MHz, CDCl3) δ 2.72-2.60 (m, 4H), 2.32 (t, J = 7 Hz, 2H), 
2.00-1.97 (m, 1H), 1.90-1.87 (m, 1H), 1.83-1.80 (m, 2H), 1.47-1.42 (m, 2H), 1.23 (s, 
3H);  13C NMR (125 MHz, CDCl3) δ 210.49, 179.27, 65.70, 38.18. 36.15, 34.09, 20.11, 
20.06, 17.91; LRMS (ESI) Cacld for C11H16O4 [M-H]: 211.  Found: 211. 
Keto-acid 3.22b;(n = 1):  
 The 2-methyl-1,3-cyclopentadione 3.15b (1.02 g, 9.10 mmol) was converted to 
the allylated dione (495.3 mg, 36%) which was subsequently made into the benzyl ester 
(641.2 mg, 69%) via Grubb's catalyst procedures.  The ester was then was converted to 
the corresponding keto-acid using the representative procedure above to yield acid 3.22b 
(281.4 mg, 63%) as a white solid:  IR (thin film) 3600-2600 cm-1; 1717 cm-1; 1H NMR 
(500 MHz, CDCl3) δ 2.80-2.72 (m, 4H), 2.27 (t, J = 7.5, 2H), 1.65-1.62 (m, 2H), 1.49-
1.44 (m, 2H), 1.10 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 216.61, 179.05, 56.80, 
35.43, 34.53, 34.10, 19.88, 19.45; LRMS (ESI) Calcd for C10H14O4 [M-H]: 197. Found: 
197. 
 
                                                 
5 Hon, Y.S.; Lu, L.; Chang, R.C.; Lin, S.W.; Sun, P.P.; Lee, C.F. Tetrahedron, 2000, 56, 9269 
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Representative Procedure for the keto-acid of the 7 and 8 membered diones: 
O
O
n
3.21c/d
O
OBn
H2, Pd/C
MeOH, 21 oC
O
O
n
3.22c/d
O
OH
 
Keto-acid 3.22c;(n = 3):   
 The benzyl ester 3.21c (2.14 g, 6.812 mmol) was then hydrogenated under 
established conditions to yield the keto-acid, 3.22c (1.2 g, 78%) as a white solid:  IR 
(thin film) 3550-2500 cm-1, 1694 cm-1; 1H NMR (500 MHz, CDCl3) δ 2.44 (app d, J = 
3.5, 4H), 2.33 (t, J = 7, 2H), 1.87-1.85 (qt, 4H), 1.82-1.79 (m, 2H), 1.40-1.37 (m, 2H), 
1.19 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 212.97, 179.48, 64.76, 41.49, 34.24, 33.10, 
28.36, 19.17, 18.04; LRMS (ESI) Calcd for C12H18O4 [M-H]: 225. Found: 225. 
Keto-acid 3.22d;(n = 4):   
 The benzyl ester 3.21d (821.8 mg, 2.50 mmol) was subjected to the 
representative procedure outlined above to give the keto-acid 3.22d (393 mg, 65%) as a 
white solid:  IR (thin film): 3570-2750 cm-1, 1688 cm-1; 1H NMR (500 MHz, CDCl3) δ 
2.38 (t, J = 6, 4H), 2.32 (t, J = 7.5, 2H), 1.79-1.75 (m, 2H), 1.66-1.60 (m, 4H), 1.52-1.47 
(m, 2H), 1.37-1.30 (m, 2H), 1.19 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 211.35, 
179.35, 65.09, 41.22, 34.14, 32.91, 27.24, 25.31, 19.06, 17.91; LRMS (ESI) Calcd for 
C13H20O4 [M-H]: 239.  Found: 239. 
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Benzyl ester 3.32: 
O
O
O
Ph3PCHCO2Bn
CHCl3,
overnight
O
O
OBn
O
3.323.31  
 Procedure was based upon the work done by Huddleston et. al.6.  The aldehyde 
3.31 (1 g, 5.95 mmol, 1 equiv.) was dissolved in 40 mL chloroform and to this was 
added the solid Wittig reagent (4.88 g, 11.899 mmol, 2 equiv.).  The solution becomes 
green and then blue.  After stirring overnight (16 h) at reflux, the solution remained a 
constant clear yellow.  The solution was cooled, concentrated and purified via flash 
column chromatography on SiO2 (0-5-10% EtOAc/Hex) and the pure ester 3.32 (1.48 g, 
83%) was isolated.  IR (thin film):  1720 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.37-7.27 
(m, 5H), 6.87-6.84 (td, J = 7, 16, 1H), 5.84-5.81 (d, J = 15.5, 1H), 5.17 (s, 2H), 2.84-
2.70 (m, 4H), 2.11-2.09 (m, 2H), 1.82-1.79 (m, 2H), 1.15 (s, 3H); 13C NMR (125 MHz, 
CDCl3) δ 216.20, 147.95, 136.31, 128.90, 128.56, 128.51, 127.57, 122.31, 66.49, 56.44, 
35.36, 32.96, 27.62, 20.27; LRMS (APCI) Calcd for C18H20O4 [M+Li]:  300.  Found:  
300. 
 
 
 
 
 
                                                 
6 Huddleston, R. R.; Krische, M. J. Org. Lett. 2003, 5, 1143 
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Benzyl ester 3.36: 
Ph3PCHCO2Bn
CHCl3, 16 h,
O
O
O
O
O
O
OBn
3.35 3.36  
 The starting dione 3.35 (402.9 mg, 2.40 mmol) was subjected to the procedure 
above.  After stirring overnight, the cooled mixture was concentrated and directly 
purified via flash column chromatography on SiO2 (30-40-50-60% EtOAc/Hex) and the 
pure ester 3.36 (582 mg, 74%) was isolated as a pale yellow oil.  IR (thin film):  1696 
cm-1;  1H NMR (500 MHz, CDCl3) δ 7.36-7.33 (m, 5H), 7.22-7.17 (dd, J = 11.5, 15.5, 
1H), 6.19-6.17 (dd, J = 1, 11, 1H), 5.89-5.85 (m, 2H), 5.17 (s, 2H), 2.73-2.56 (m, 6H), 
1.96-1.90 (m, 2H), 1.29 (s, 3H);  13C NMR (125 MHz, CDCl3) δ 209.98, 209.91, 167.06, 
144.60, 132.51, 136.38, 138.28, 128.88, 128.52, 120.93, 66.48, 65.30, 39.05, 38.44, 
22.15, 17.67;  LRMS (ESI) Calcd for C20H22O4 [M+Li]:  333.  Found:  333. 
Keto-acid 3.37: 
O
O
H2, Pd/C
MeOH, rt, 16 h
O
O
3.36
3.37
O
OBn
O
OH
 
 The benzyl ester 3.36 was subjected to a typical hydrogenation procedure.  3.36 
(542.7 mg, 1.66 mmol, 1 equiv.) was weighed out in a 50 mL RBF and dissolved in 16 
mL freshly distilled MeOH.  Palladium on activated carbon (approx. 40 mg) was added 
and the flask was purged several times with H2 and allowed to stir for 16 hours at rt 
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under H2 atm.  The mixture was poured through celite, concentrated in vacuo and then 
purified via flash column chromatography on SiO2 (40-50-60% EtOAc/Hex with 1% 
AcOH) and the pure acid (230.5 mg, 57.8 %) was isolated.  IR (thin film):  3464 cm-1, 
1723 cm-1, 1690 cm-1; 1H NMR (500 MHz, CDCl3) δ 2.67-2.61 (m, 4H), 2.31-2.28 (t, J 
= 7.5, 2H), 2.00-1.96 (m, 1H), 1.88-1.84 (m, 1H), 1.77-1.74 (m, 2H), 1.60-1.54 (m, 2H), 
1.31-1.25 (m, 2H), 1.20 (s, 3H), 1.14-1.09 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 
210.85, 180.08, 65.84, 38.25, 37.38, 34.11, 29.47, 24.64, 24.52, 19.63, 17.94; LRMS 
(ESI) Calcd for C13H20O4 [M-H]:  239.  Found:  239. 
Imine 3.42: 
Br
N
O
OBn N
O
OBnKOtBu, 12h,
THF, -78oC rt
3.41 3.42
>
 
 Potassium tert-butoxide (3 mL, 3 mmol, 1M in THF) and 9 mL of THF were 
combined in a 10 mL RBF and cooled to -78oC.  Upon addition of the imine (987.4 mg, 
3 mmol, 1 equiv.) in 3 mL THF, the solution becomes bright yellow.  Then the alkyl 
halide (0.39 mL, 3.3 mmol, 1.1 equiv.) was slowly added and the mixture was let to stir 
for 12 h while warming to rt.  The mixture was then poured into sat. NH4cl sol, the 
organics were extracted with EtOAc (x3), washed with sat. NH4Cl sol. (x3), dried over 
MgSO4, filtered and concentrated.  The crude product was purified via flash column 
chromatography on SiO2 (0-5-10% EtOAc/Hex) and the pure alkylated imine 3.42 (517 
mg, 43%).  IR (thin film):  1741 cm-1, 1664 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.83 
(dd, J = 1.5, 8.5, 3H), 7.66 (dd, J = 1, 8.5, 2H), 7.63-7.59 (tt, J = 1.5, 7, 1H), 7.53-7.48 
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(dt, J = 1.5, 7.5, 3H), 7.43-7.38 (m, 4H), 7.37-7.32 (m, 6H), 7.14-7.11 (dd, J = 1.5, 7.5, 
2H), 5.80-5.71 (m, 1H), 5.24-5.13 (ddd, J = 12.5, 12.5, 12.5, 2H), 4.98-4.91 (m, 2H), 
4.12 (t, J = 6.5, 1H), 2.02-1.95 (dddd, J = 8, 8, 8, 8, 4H), 1.47-1.38 (m, 1H0, 1.36-1.26 
(m, 1H); 13C NMR (125 MHz, CDCl3) δ 197.32, 172.68, 171.12, 140.05, 138.97, 138.17, 
136.96, 136.55, 132.99, 130.90, 130.63, 129.39-128.39, 115.23, 66.96, 65.89, 33.97, 
33.66, 25.80; LRMS (ESI) Calcd for C27H27NO2 [M+H]:  398.  Found:  398. 
Tosyl amine 3.44: 
H2N
OBn
O
TsCl, TEA
DCM, 14 h
0oC-->rt
TsN
OBn
OH
3.43 3.44  
 The starting benzylated amino acid 3.43 (303.8 mg, 0.90 mmol, 1 equiv.) was 
dissolved in 11 mL DCM in a 25 mL RBF.  To this was added tosyl chloride, TsCl 
(188.73 mg, 0.99 mmol, 1.1 equiv.) in 2 mL DCM and then the solution was cooled to 
0oC.  TEA (0.14 mL, 1.8 mmol, 2 equiv.) was added and then the solution was let to stir 
for 14 h while warming to rt.  pH 7 buffer was poured into the reaction and was stirred 
vigorously for about 15 minutes.  The organics were then extracted with DCM (x3) and 
dried over MgSO4, filtered and concentrated.  The crude product was purified via flash 
column chromatography on SiO2 (10-20-30-40% EtOAc/Hex) and the pure tosylated 
amine 3.44 (423.8 mg, 99%) was isolated.  IR (thin film):  3284 cm-1, 2928 cm-1, 1726 
cm-1; 1H NMR (500 MHz, CDCl3) δ 7.73 (d, J = 8, 2H), 7.34-7.31 (dd, J = 2,5, 3H), 
7.23-7.19 (dd, J = 2.5, 7, 4H), 5.70-5.64 (m, 2H), 4.96-4.92 (m, 1H), 4.91 (s, 2H), 4.01-
3.97 (m, 1H), 2.38 (s, 3H), 2.03-1.94 (m, 2H), 1.79-1.70 (m, 1H), 1.68-1.59 (m, 1H), 
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1.46-1.36 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 171.72, 143.55, 137.84, 137.01, 
135.06, 129.69, 128.64, 128.55, 128.26, 127.30, 115.18, 67.24, 55.75, 32.94, 32.75, 
24.15, 21.61; LRMS (ESI) Calcd for C21H25NO4S [M+H]:  388.  Found:  388. 
Tosyl amine 3.45: 
TsN
OBn
OH
3.44
TsN
OBn
OH
O
3.45
PdCl2, O2 atm.
DMA:H2O,
80oC, 4 h
 
 The catalyst, PdCl2 (1 mg, 0.0056 mmol, 0.01 equiv.) was weighed in a 25 mL 
RBF and diluted with 5 mL DMA and 0.3 mL H2O.  The flask was purged with O2 atm. 
and was let to stir for 4 h at reflux.  The starting material 3.44 (217.5 mg, 0.562 mmol, 1 
equiv.) in 1 mL DMA was added and the mixture was stirred vigorously for 6.5 h at 
80oC under O2 atm.  After cooling, the reaction was poured into an ether/water mixture 
and the organics were extracted (x2) with ether, dried over MgSO4, filtered and 
concentrated.  The crude product was purified via flash column chromatography on SiO2 
(20-30-40% EtOAc/Hex) and the pure keto-ester 3.45 (142.3 mg, 63%) was isolated.  IR 
(thin film):  1744 cm-1, 1714 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.69-7.67 (d, J = 8, 
2H), 7.33-7.30 (dd, J = 2, 4, 2H), 7.22-7.17 (m, 4H), 5.56 (d, J = 9, 1H), 4.89 (d, J = 2, 
2H), 3.94-3.91 (m, 1H), 2.40-2.33 (m, 2H), 2.37 (s, 3H), 2.06 (s, 3H), 1.77-1.68 (m, 1H), 
1.67-1.56 (m, 3H); 13C NMR (125 MHz, CDCl3) δ 208.31, 171.58, 143.77, 136.89, 
135.02, 129.82, 128.71, 128.42, 127.38, 67.50, 55.70, 55.68, 42.58, 32.62, 30.00, 21.74, 
19.29; LRMS (ESI) Calcd for C21H25NO5S [M+H]:  404  Found:  404. 
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Keto-acid 3.46: 
TsN
OBn
OH
O
3.45
TsN
OH
OH
O
3.46
H2, Pd/C
MeOH,
rt, 4 h
 
 The starting keto-ester 3.45 (184.9 mg, 0.459 mmol, 1 equiv.) was weighed out 
in a 25 mL RBF and dissolved in 7 mLs of MeOH.  The palladium on activated carbon 
(approx. 25 mg) was added and then the flask was purged with H2 atm. and was let to 
stir for 4 h at rt.  The mixture was then passed through celite and then the crude product 
was purfied via flash column chromatography on SiO2 (50-60-70-80% EtOAc/Hex) and 
the pure keto-acid 3.46 (125.6 mg, 87%) was isolated.  IR (thin film):  3600-2900 cm-1 
(broad), 1723 cm-1, 1638 cm-1; 1H NMR (500 MHz, CD3OD) δ 7.76 (d, J = 8.5, 2H), 
7.36 (d, J = 8, 2H), 5.00 (bs, 2H), 3.82 (t, J = 4.5, 7.5, 1H), 2.47-2.43 (t, J = 7, 2H), 2.43 
(s, 3H), 2.11 (s, 3H), 1.77-1.68 (m, 1H), 1.65-1.54 (m, 3H); 13C NMR (125 MHz, 
CDCl3) δ 212.08, 175.51, 145.48, 139.99, 131.41, 129.00, 57.68, 44.00, 33.99, 30.63, 
22.33, 21.46; LRMS (ESI) Calcd for C14H19NO5S [M-H
+]:  312  Found:  312.  
Aldehyde 3.61: 
O
O
O3, DCM
-78oC-->rt, 16 h
O
O
O
3.15a 3.61  
 The allylated dione 3.61 (310.3 mg, 1.87 mmol, 1 equiv.) was weighed out in a 
50 mL RBF and diluted with 8 mL DCM.  The solution was cooled thoroughly to -78oC 
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and then ozone was bubbled in through a gas dispersion tube until the solution was a 
consistant light blue color.  Atmospheric O2 was then bubbled in until the original pale 
yellow color returned and then DMS (0.7 mL, 9.34 mmol, 5 equiv.) was added.  The 
reaction was allowed to stir at -78oC while warming to rt over 16 hours.  The reaction 
was quenched with brine and diluted with DCM.  The organics were extracted with 
DCM (x2), washed with brine (x2), dried over MgSO4, filtered and concentrated.  The 
crude product was purified via flash column chromatography on SiO2 (20-30-40-50% 
EtOAc/Hex) and the pure aldehyde (71.2 mg, 25%) was isolated.  IR (thin film):  3550-
3000 cm-1 (broad), 1697 cm-1; 1H NMR (500 MHz, CDCl3) δ 9.52 (s, 1H), 3.27 (s, 2H), 
2.74-2.71 (dd, J = 5.5, 7.5, 4H), 2.19-2.13 (m, 1H), 2.12-2.05 (m, 1H), 1.28 (s, 3H); 13C 
NMR (125 MHz, CDCl3) δ 210.22, 199.77, 59.72, 49.97, 37.73, 23.53, 17.64; LRMS 
(ESI) Calcd for C9H12O3 [M+Li]:  175.  Found:  175.    
 79 
REFERENCES 
 
1.  (a) Borrmann, D.; Wegler, R. Chem. Ber. 1966, 99, 1245.  (b) Borrmann, D.; 
 Wegler, R. Chem. Ber. 1967, 100, 1575.  (c) Borrmann, D.; Wegler, R. Chem. 
 Ber. 1969, 102, 64. 
 
2.  (a) Wynberg, H.; Staring, E. G.J. J. Am. Chem. Soc. 1982, 104, 166. (b)  
 Wynberg, H.; Staring, E. G.J.; J. Org. Chem. 1985, 50, 1977. 
 
3.  For examples of use of cinchona alkaloids towards β-lactone formation see:  (a) 
 Ramiandrasoa, P.; Guérin, P.; Girault, J. P.; Bascou, P.; Hammouda, A.; 
 Cammas, S.; Vert, M. Polym. Bull. 1993, 30, 501. (b) Song, C. E.; Ryu, T. H.; 
 Roh, E. J.; Kim, I. O. Tetrahedron: Asymmetry 1994, 5, 1215. (c) Calter, M. A.; 
 Guo, X.; Liao, W. Org. Lett. 2001, 3, 1499. 
 
4.  (a)  Calter, M. A.; Orr, R. K.; Song, W. Org. Lett. 2003, 5, 4745.  (b) Calter, M. 
 A. J. Org. Chem. 1996, 61, 8006. (c) Calter, M. A.; Guo, X. J. Org. Chem. 1998, 
 63, 5308. 
 
5.  (a)  Brady, W. T.; Giang, Y. F. J. Org. Chem. 1986, 51, 2147. (b)  Brady, W. T.; 
 Giang, Y. F.; Marchand, A. P.; Wu, A. J. Org. Chem. 1987, 52, 3457. 
 
6.  http://www.nottingham.ac.uk/~pczbl/cinch.html. 
 
7.  Tennyson, R.; Romo, D.; J. Org. Chem. 2000, 65, 7248.  
 
8.  Cortez, S.G.; Tennyson, R.; Romo, D.; J. Am.Chem. Soc. 2001, 123, 7945. 
 
9.  (a) Dijkstra, G. D. H.; Kellogg, R. M.; Wynberg, H. Recl. Trav. Chim. Pays-Bas 
 1989, 108, 195. (b) Dijkstra, G. D. H.; Kellogg, R. M.; Wynberg, H.; Svendsen, 
 J. S.; Marko, I.; Sharpless, K. B. J. Am. Chem. Soc. 1989, 111, 8069. (c) Dijkstra, 
 G. D. H.; Kellogg, R. M.; Wynberg, H. J. Am. Chem. Soc. 1990, 112, 6121. 
 
10.  Cortez, G. S.; Oh S.-H.; Romo, D. Synthesis (Special Topics) 2001, 1731. 
 
11.  Zhu, C.; Shen, X.; Nelson, S. G.; J. Am. Chem. Soc. 2004, 126, 5352. 
 
12.  Shen, X.; Wasmuth, A. S.; Zhao, J.; Zhu, C.; Nelson, S. G. J. Am. Chem. Soc. 
 2006, 128, 7438. 
 
13.  Calter, M. A.; Tretyak, O. A.; Flaschenriem, C. Org. Lett. 2005, 7, 1809. 
 
14.  Arduengo, A. J. III.; Harlow, R. L.; Kline, M. J. Am. Chem. Soc. 1991, 113, 361.  
 80 
 
15.  (a) Burstein, C.; Glorius, F. Angew. Chem. Int. Ed. 2004, 43, 6205.  (b) Burstein, 
 C.; Tschan, S.; Xie, X.; Glorius, F. Synthesis, 2006, 14, 2418. 
 
16.  Nair, V.; Vellalath, S.; Poonoth, M.; Suresh, E. J. Am. Chem. Soc. 2006, 128, 
 8736. 
 
17.  Wadamoto, M.; Phillips, E. M.; Reynolds, T. E.; Scheidt, K. A. J. Am. Chem. 
 Soc. 2007, 129, 10098. 
 
18.  Sohn, S. S.; Rosen, E. L.; Bode, J. W. J. Am. Chem. Soc. 2004, 126, 14370. 
 
19.  Merlic, C. A.; Doroh, B. C. J. Org. Chem. 2003, 68, 6056. 
 
20.  (a) Fu, G. C. Acc. Chem. Res. 2000, 33, 412.  (b) Arai, S.; Bellemin-Laponnaz, 
 S.; Fu, G. C. Angew. Chem., Int. Ed. 2001, 40, 234. (c) Hodous, B. L.; Fu, G. C. 
 J. Am. Chem. Soc. 2002, 124, 1578. (d) Wilson, J. E.; Fu, G. C. Angew. Chem. 
 Int. Ed. 2004, 43, 6358. 
 
21.  Henry-Riyad, H.; Lee, C. S.; Purohit, V.; Romo, D. Org. Lett. 2006, 8, 4363. 
 
22.  (a) Ma, G.; Nguyen, H.; Romo, D. Org. Lett. 2007, 9, 2143. (b) Calter, M. A.; 
 Liao, W.; Struss, J. A. J. Org. Chem. 2001, 66, 7500. 
 
23.  Zhang, W.; Matla, A. S.; Romo, D., Org. Lett., 2007, 9, 2111. 
 
24.  Ashby, E. C.; Goel, A. B. J. Org. Chem. 1983, 48, 2425. 
 
25.  (a) Sato, T.; Kawara, T.; Kawashima, M.; Fujisawa, T. Chem. Lett. 1980, 571. (b) 
 Sato, T.; Kawara, T.; Nishizawa, A.; Fujisawa, T. Tetrahedron Lett. 1980, 21, 
 3377. (c) Fujisawa, T.; Sato, T.; Kawara, T.; Ohashi, K. Tetrahedron Lett. 1981, 
 22, 4823. (d) Sato, T.; Naruse, K.; Fujisawa, T. Tetrahedron Lett. 1982, 23, 3587. 
 (e) Sato, T.; Itoh, T.; Hatori, C.; Fujisawa, T. Chem. Lett. 1983, 1391. (f) 
 Kawashima, M.; Sato, T.; Fujisawa, T. Tetrahedron  1989, 45, 403. 
 
26.  Normant, J. F.; Alexakis, A.; Cahiez, G. Tetrahedron Lett. 1980, 21, 935.   
 
27.  Arnold, L. D.; Drover, J. C. G; Vederas, J. C. J. Am. Chem. Soc. 1987, 109, 
 4649. 
 
28.  (a) Nelson, S. G.; Wan, Z.; Stan, M. A. J. Org. Chem. 2002, 67, 4680. (b) Smith, 
 N. D.; Wohlrab, A. M.; Goodman, M. Org. Lett. 2005, 7, 255. 
 
 81 
 
29. Conlon, D. A.; Jensen, M. S.; Plaucki, M.; Yasuda, N.; Um, J. M.; Yang, C.; 
 Hartner, F. W.; Tsay, F.-R.; Hsiao, Y.; Pye, P.; Rivera, N. R.; Hughes, D. L.  
 Chirality  2005, 17, S149. 
 
30. Palucki, M.; Um, J. M.; Yasuda, N.; Conlon, D. A.; Tsay, F. R.; Hartner, F. W.; 
 Hsiao, Y.; Marcune, B.; Karady, S.; Hughes, D. L.; Dormer, P. G.; Reider, P. J. 
 J. Org. Chem. 2002, 67, 5508. 
 
31. (a) Oh, S. H.; Cortez, G. S.; Romo, D. J. Org. Chem. 2005, 70, 2835. (b) Oh, S.; 
 Henry-Riyad, H.; Nguyen, H.; Romo, D. Organic Syntheses, 2005, submitted. 
 
32.  For reviews see:  (a) Wang, Y.; Tennyson, R.L.; Romo, D, Heterocycles, 2004, 
 64, 605. (b) Pommier, A.; Pons, J-M. Synthesis 1993, 441. (c) Zhu, C.; Shen, X.; 
 Nelson, S.G. J. Am. Chem. Soc. 2004, 126, 5352. (d) Wilson, J.E.; Fu, G. Agnew. 
 Chem. Int. Ed. 2004, 43, 6358. (e) Calter, M.A.; Tretyak, O.A.; Flaschernriem, 
 C. Org. Lett. 2005, 7, 1809. (f) Oh, S.H.; Cortez, G.S.; Romo, D. J. Org. Chem. 
 2005, 70, 2835. (g) Gnanadesikan, V.; Corey, E.J.; Org. Lett. 2006, 8, 4943. (h) 
 Kramer, J.W.; Lobkovsky, E.B.; Coates, G.W. Org. Lett. 2006, 8, 3709. 
 
33.  Stahl, P.; Kissau, L.; Mazitschek, R.; Huwe, A.; Furet, P.; Giannis, A.; 
 Waldmann, H.  J. Am.. Chem. Soc., 2001, 123, 11586. 
 
34.  Fujiwara, M.; Hitomi, K.; Baba, A.; Matsuda, H. Chem. Lett. 1994, 23, 875. 
 
35.  Bedekar, A.V.; Watanabe, T.; Tanaka, K.; Fuji, K. Synthesis, 1995, 1069. 
 
36. Katoh, T.; Mizumoto, S.; Fudesaka, M.; Takeo, M.; Kajimoto, T.; Node, M. 
 Tetradedron:  Asymmetry 2006, 17, 1655. 
 
37.  Mori, K.; Fujiwhara, M. Tetrahedron, 1988, 44, 343. 
 
38.  Chatterjee, A.K.; Choi, T.L.; Sanders, D.P.; Grubbs, R. H. J. Am. Chem. Soc. 
 2003, 125, 11360. 
 
39.  Hon, Y.S.; Lu, L.; Chang, R.C.; Lin, S.W.; Sun, P.P.; Lee, C.F. Tetrahedron, 
 2000, 56, 9269. 
 
40.  (a) Lewicka-Piekut, S.; Okamura, W.H. Synth. Comm., 1980, 10, 415.  (b) 
 Brooks, D.W.; Mazdiyasni, H.; Sallay, P. J. Org. Chem. 1985, 50, 3411.  (c) 
 Letsinger, R.L.; Kammeyer, C.W. J. Am. Chem. Soc. 1951, 73, 4476. 
 
41.  Huddleston, R.R.; Krische, M.J. Org. Lett. 2003, 5, 1143. 
 
 82 
 
42.  (a) Carey, F.A.; Sundberg, R.J. Advanced Organic Chemistry; Kluwer Academic 
 / Plenum Publishers:  New York, 2000; p 146. (b) Clayden, J.; Greeves, N.; 
 Warren, S.; Wothers, P. Organic Chemistry;  Oxford Press: Oxford, 2005; p 455. 
 
43.  (a) Pickard, P.L.; Tolbert, T.L. Organic Syntheses; Wiley & Sons:  New York, 
 1973; Collect. Vol. V, p 520.  (b) O'Donnell, M.J.; Polt, R.L. J. Org. Chem. 
 1982, 47, 2663. 
  
44.  (a) O'Donnell, M.J.; Boniece, J.M.; Earp, S.E. Tetrahedron Letters, 1978, 19, 
 2641.  (b) O'Donnell, M.J.; Bennett, W.D.; Wu, S. J. Am. Chem. Soc. 1989, 111, 
 2353. 
 
45. Stork, G.; Leong, A. Y. W.; Touzin, A. M. J. Org. Chem., 1976, 41, 3491. 
 
46.  Yamada, S.I.; Oguri, T.; Shioiri, T. Chem Comm. 1976, 136. 
 
47.  McDonald, I.A.; Nyce, P.L.; Jung, M.J.; Sabol, J.S.; Tett. Lett. 1991, 32, 887. 
 
48.  Upadhyaya, P.; McIntee, E.J.; Villalta, P.W.; Hecht, S.S. Chem. Res. Toxicol, 
 2006, 19, 426. 
 
49.  Mitsudome, T.; Umetani, T.; Nosaka, N.; Mori, K.; Mizugaki, T.; Ebitani, K.; 
 Kaneda, K.  Angew. Chem. Int. Ed. 2006, 45, 481. 
 
50.  Ashby, E. C., DePriest, R. N., Tuncay, A., Srivastava, S., Tet. Lett., 2004, 50, 
 5251. 
 
51.  (a) Danishefsky, S. J.; Armistead, D. M.; Wincott, F. E.; Selnick, H. G.; Hungate, 
 R. J. Am. Chem. Soc. 1989, 111, 2967.  (b) Bennek, J. A.; Gray, G. R. J. Org. 
 Chem.  1987, 52, 892. 
 
52.  (a) de Fátima, A. Synlett, 2005, 11, 1805.  (b)  Tao, C.; Donaldson, W. A. J. Org. 
 Chem. 1993, 58, 2134. (c)  Mahoney, W. S.; Brestensky, D. M.; Stryker, J. M.; J. 
 Am. Chem. Soc. 1988, 110, 291. (d)  Brestensky, D. M.; Huseland, D. E.; 
 McGettingan, C.; Stryker, J. M. Tetrahedron Lett. 1988, 29, 3749. 
 
 
 
 
 
 
  
 
 83 
 
APPENDIX A 
 
SELECTED SPECTRAL DATA 
 
 
 
 
  
84 
 
 
 
 
 
0.
5
0.
5
1.
0
1.
0
1.
5
1.
5
2.
0
2.
0
2.
5
2.
5
3.
0
3.
0
3.
5
3.
5
4.
0
4.
0
4.
5
4.
5
5.
0
5.
0
5.
5
5.
5
6.
0
6.
0
6.
5
6.
5
7.
0
7.
0
7.
5
7.
5
8.
0
8.
0
8.
5
8.
5
9.
0
9.
0
O
O
3
.1
9
a
O
1 H
 N
M
R
 s
pe
ct
ru
m
 f
or
 T
ri
cy
cl
ic
 β
-l
ac
to
ne
 3
.1
9
a
 (
C
D
C
l 3
) 
  
85 
 
 
 
13
C
 N
M
R
 s
pe
ct
ru
m
 f
or
 T
ri
cy
cl
ic
 β
-l
ac
to
ne
 3
.1
9
a
 (
C
D
C
l 3
) 
O
O
O
3
.1
9
a
  
86 
 
 
 
0.
5
0.
5
1.
0
1.
0
1.
5
1.
5
2.
0
2.
0
2.
5
2.
5
3.
0
3.
0
3.
5
3.
5
4.
0
4.
0
4.
5
4.
5
5.
0
5.
0
5.
5
5.
5
6.
0
6.
0
6.
5
6.
5
7.
0
7.
0
7.
5
7.
5
8.
0
8.
0
8.
5
8.
5
9.
0
9.
0
O
O
3
.1
9
b
O
1 H
 N
M
R
 s
pe
ct
ru
m
 f
or
 T
ri
cy
cl
ic
 β
-l
ac
to
ne
 3
.1
9
b
 (
C
D
C
l 3
) 
  
87 
 
 
13
C
 N
M
R
 s
pe
ct
ru
m
 f
or
 T
ri
cy
cl
ic
 β
-l
ac
to
ne
 3
.1
9
b
 (
C
D
C
l 3
) 
O
O
3
.1
9
b
O
  
88 
 
 
0.
5
0.
5
1.
0
1.
0
1.
5
1.
5
2.
0
2.
0
2.
5
2.
5
3.
0
3.
0
3.
5
3.
5
4.
0
4.
0
4.
5
4.
5
5.
0
5.
0
5.
5
5.
5
6.
0
6.
0
6.
5
6.
5
7.
0
7.
0
7.
5
7.
5
8.
0
8.
0
8.
5
8.
5
9.
0
9.
0
O
O
3
.1
9
c
O
1 H
 N
M
R
 s
pe
ct
ru
m
 f
or
 T
ri
cy
cl
ic
 β
-l
ac
to
ne
 (
sy
n
)-
3
.1
9
c
 (
C
D
C
l 3
) 
O
O
O
(s
y
n
)-
3
.1
9
c
  
89 
 
 
13
C
 N
M
R
 s
pe
ct
ru
m
 f
or
 T
ri
cy
cl
ic
 β
-l
ac
to
ne
 (
sy
n
)-
3
.1
9
c
 (
C
D
C
l 3
) 
O
O
O
(s
y
n
)-
3
.1
9
c
  
90 
 
 
 
0.
5
0.
5
1.
0
1.
0
1.
5
1.
5
2.
0
2.
0
2.
5
2.
5
3.
0
3.
0
3.
5
3.
5
4.
0
4.
0
4.
5
4.
5
5.
0
5.
0
5.
5
5.
5
6.
0
6.
0
6.
5
6.
5
7.
0
7.
0
7.
5
7.
5
8.
0
8.
0
8.
5
8.
5
9.
0
9.
0
O
O
O
1 H
 N
M
R
 s
pe
ct
ru
m
 f
or
 T
ri
cy
cl
ic
 β
-l
ac
to
ne
 (
a
n
ti
)-
3
.1
9
c
 (
C
D
C
l 3
) 
O
O
O
(a
n
ti
)-
3
.1
9
c
  
91 
 
 
13
C
 N
M
R
 s
pe
ct
ru
m
 f
or
 T
ri
cy
cl
ic
 β
-l
ac
to
ne
 (
a
n
ti
)-
3
.1
9
c
 (
C
D
C
l 3
) 
O
O
O
(a
n
ti
)-
3
.1
9
c
  
92 
 
 
 
0.
5
0.
5
1.
0
1.
0
1.
5
1.
5
2.
0
2.
0
2.
5
2.
5
3.
0
3.
0
3.
5
3.
5
4.
0
4.
0
4.
5
4.
5
5.
0
5.
0
5.
5
5.
5
6.
0
6.
0
6.
5
6.
5
7.
0
7.
0
7.
5
7.
5
8.
0
8.
0
8.
5
8.
5
9.
0
9.
0
O
3
.1
9
dOO
1 H
 N
M
R
 s
pe
ct
ru
m
 f
or
 T
ri
cy
cl
ic
 β
-l
ac
to
ne
 (
sy
n
)-
3
.1
9
d
 (
C
D
C
l 3
) 
O
(s
y
n
)-
3
.1
9
d
O
O
  
93 
 
 
 
 
 
 
2525
5050
7575
10
0
10
0
12
5
12
5
15
0
15
0
17
5
17
5
20
0
20
0
O
3
.1
9
dOO
13
C
 N
M
R
 s
pe
ct
ru
m
 f
or
 T
ri
cy
cl
ic
 β
-l
ac
to
ne
 (
sy
n
)-
3
.1
9
d
 (
C
D
C
l 3
) 
O
(s
y
n
)-
3
.1
9
d
O
  
94 
 
 
 
0.
5
0.
5
1.
0
1.
0
1.
5
1.
5
2.
0
2.
0
2.
5
2.
5
3.
0
3.
0
3.
5
3.
5
4.
0
4.
0
4.
5
4.
5
5.
0
5.
0
5.
5
5.
5
6.
0
6.
0
6.
5
6.
5
7.
0
7.
0
7.
5
7.
5
8.
0
8.
0
8.
5
8.
5
9.
0
9.
0
O
3
.1
9
dOO
1 H
 N
M
R
 s
pe
ct
ru
m
 f
or
 T
ri
cy
cl
ic
 β
-l
ac
to
ne
 (
a
n
ti
)-
3
.1
9
d
 (
C
D
C
l 3
) 
(a
n
ti
)-
3
.1
9
d
O
O
  
95 
 
 
2525
5050
7575
10
0
10
0
12
5
12
5
15
0
15
0
17
5
17
5
20
0
20
0
O
3
.1
9
dOO
13
C
 N
M
R
 s
pe
ct
ru
m
 f
or
 T
ri
cy
cl
ic
 β
-l
ac
to
ne
  (
a
n
ti
)-
3
.1
9
d
 (
C
D
C
l 3
) 
(a
n
ti
)-
3
.1
9
d
O
O
  
96 
 
 
 
0.
5
0.
5
1.
0
1.
0
1.
5
1.
5
2.
0
2.
0
2.
5
2.
5
3.
0
3.
0
3.
5
3.
5
4.
0
4.
0
4.
5
4.
5
5.
0
5.
0
5.
5
5.
5
6.
0
6.
0
6.
5
6.
5
7.
0
7.
0
7.
5
7.
5
8.
0
8.
0
8.
5
8.
5
9.
0
9.
0
O
O
O
3
.3
4
1 H
 N
M
R
 s
pe
ct
ru
m
 f
or
 T
ri
cy
cl
ic
 β
-l
ac
to
ne
 3
.3
4
 (
C
D
C
l 3
) 
  
97 
 
 
 
13
C
 N
M
R
 s
pe
ct
ru
m
 f
or
 T
ri
cy
cl
ic
 β
-l
ac
to
ne
 3
.3
4
 (
C
D
C
l 3
) 
O
O
O
3
.3
4
  
98 
 
 
 
0.
5
0.
5
1.
0
1.
0
1.
5
1.
5
2.
0
2.
0
2.
5
2.
5
3.
0
3.
0
3.
5
3.
5
4.
0
4.
0
4.
5
4.
5
5.
0
5.
0
5.
5
5.
5
6.
0
6.
0
6.
5
6.
5
7.
0
7.
0
7.
5
7.
5
8.
0
8.
0
8.
5
8.
5
9.
0
9.
0
O
O
3
.2
0
c
1 H
 N
M
R
 s
pe
ct
ru
m
 f
or
 a
ll
yl
 d
io
ne
 3
.2
0
c
 (
C
D
C
l 3
) 
  
99 
 
 
 
 
 
 
2
5
2
5
5
0
50
7
5
7
5
1
0
0
1
0
0
12
5
1
2
5
1
5
0
1
5
0
17
5
1
7
5
2
0
0
2
00
O
O
3
.2
0
c
13
C
 N
M
R
 s
pe
ct
ru
m
 f
or
 a
ll
yl
 d
io
ne
 3
.2
0
c
 (
C
D
C
l 3
) 
  
100 
 
 
 
0.
5
0.
5
1.
0
1.
0
1.
5
1.
5
2.
0
2.
0
2.
5
2.
5
3.
0
3.
0
3.
5
3.
5
4.
0
4.
0
4.
5
4.
5
5.
0
5.
0
5.
5
5.
5
6.
0
6.
0
6.
5
6.
5
7.
0
7.
0
7.
5
7.
5
8.
0
8.
0
8.
5
8.
5
9.
0
9.
0
3
.2
0
d
O
O
1 H
 N
M
R
 s
pe
ct
ru
m
 f
or
 a
ll
yl
 d
io
ne
 3
.2
0
d
 (
C
D
C
l 3
) 
  
101 
 
 
 
2525
5050
7575
10
0
10
0
12
5
12
5
15
0
15
0
17
5
17
5
20
0
20
0
3
.2
0
d
O
O
13
C
 N
M
R
 s
pe
ct
ru
m
 f
or
 a
ll
yl
 d
io
ne
 3
.2
0
d
 (
C
D
C
l 3
) 
  
102 
 
 
 
11
22
33
44
55
66
77
88
99
1010
1111
O
O
H
3
.6
0
1 H
 N
M
R
 s
pe
ct
ru
m
 f
or
 a
ll
yl
 d
io
ne
 3
.6
0
 (
C
D
C
l 3
) 
  
103 
 
 
 
 
2525
5050
7575
10
0
10
0
12
5
12
5
15
0
15
0
17
5
17
5
20
0
20
0
O
O
H
3
.6
0
13
C
 N
M
R
 s
pe
ct
ru
m
 f
or
 a
ll
yl
 d
io
ne
 3
.6
0
 (
C
D
C
l 3
) 
  
104 
 
 
 
0.
5
0.
5
1.
0
1.
0
1.
5
1.
5
2.
0
2.
0
2.
5
2.
5
3.
0
3.
0
3.
5
3.
5
4.
0
4.
0
4.
5
4.
5
5.
0
5.
0
5.
5
5.
5
6.
0
6.
0
6.
5
6.
5
7.
0
7.
0
7.
5
7.
5
8.
0
8.
0
8.
5
8.
5
9.
0
9.
0
O
O
O
O
B
n
3
.2
1
c
1 H
 N
M
R
 s
pe
ct
ru
m
 f
or
 b
en
zy
l 
es
te
r 
3
.2
1
c
 (
C
D
C
l 3
) 
  
105 
 
 
 
 
2525
5050
7575
10
0
10
0
12
5
12
5
15
0
15
0
17
5
17
5
20
0
20
0
O
O
O
O
B
n
3
.2
1
c
13
C
 N
M
R
 s
pe
ct
ru
m
 f
or
 b
en
zy
l 
es
te
r 
3
.2
1
c
 (
C
D
C
l 3
) 
  
106 
 
 
 
0.
5
0.
5
1.
0
1.
0
1.
5
1.
5
2.
0
2.
0
2.
5
2.
5
3.
0
3.
0
3.
5
3.
5
4.
0
4.
0
4.
5
4.
5
5.
0
5.
0
5.
5
5.
5
6.
0
6.
0
6.
5
6.
5
7.
0
7.
0
7.
5
7.
5
8.
0
8.
0
8.
5
8.
5
9.
0
9.
0
O
O
3
.2
1
d
O
O
B
n
1 H
 N
M
R
 s
pe
ct
ru
m
 f
or
 b
en
zy
l 
es
te
r 
 3
.2
1
d
 (
C
D
C
l 3
) 
  
107 
 
 
 
2525
5050
7575
10
0
10
0
12
5
12
5
15
0
15
0
17
5
17
5
20
0
20
0
O
O
3
.2
1
d
O
O
B
n
13
C
 N
M
R
 s
pe
ct
ru
m
 f
or
 b
en
zy
l 
es
te
r 
3
.2
1
d
 (
C
D
C
l 3
) 
  
108 
 
 
0.
5
0.
5
1.
0
1.
0
1.
5
1.
5
2.
0
2.
0
2.
5
2.
5
3.
0
3.
0
3.
5
3.
5
4.
0
4.
0
4.
5
4.
5
5.
0
5.
0
5.
5
5.
5
6.
0
6.
0
6.
5
6.
5
7.
0
7.
0
7.
5
7.
5
8.
0
8.
0
8.
5
8.
5
9.
0
9.
0
O
O
O
O
H
3
.2
2
a
1 H
 N
M
R
 s
pe
ct
ru
m
 f
or
 k
et
o-
ac
id
 3
.2
2
a
 (
C
D
C
l 3
) 
  
109 
 
 
2525
5050
7575
10
0
10
0
12
5
12
5
15
0
15
0
17
5
17
5
20
0
20
0
O
O
O
O
H
3
.2
2
a
13
C
 N
M
R
 s
pe
ct
ru
m
 f
or
 k
et
o-
ac
id
 3
.2
2
a
 (
C
D
C
l 3
) 
  
110 
 
 
 
11
22
33
44
55
66
77
88
99
1010
1111
1212
O
O
O
O
H
3
.2
2
b
1 H
 N
M
R
 s
pe
ct
ru
m
 f
or
 k
et
o-
ac
id
 3
.2
2
b
 (
C
D
C
l 3
) 
  
111 
 
 
 
2525
5050
7575
10
0
10
0
12
5
12
5
15
0
15
0
17
5
17
5
20
0
20
0
O
O
O
O
H
3
.2
2
b
13
C
 N
M
R
 s
pe
ct
ru
m
 f
or
 k
et
o-
ac
id
 3
.2
2
b
 (
C
D
C
l 3
) 
  
112 
 
 
 
0.
5
0.
5
1.
0
1.
0
1.
5
1.
5
2.
0
2.
0
2.
5
2.
5
3.
0
3.
0
3.
5
3.
5
4.
0
4.
0
4.
5
4.
5
5.
0
5.
0
5.
5
5.
5
6.
0
6.
0
6.
5
6.
5
7.
0
7.
0
7.
5
7.
5
8.
0
8.
0
8.
5
8.
5
9.
0
9.
0
O
O
O
O
H
3
.2
2
c
1 H
 N
M
R
 s
pe
ct
ru
m
 f
or
 k
et
o-
ac
id
 3
.2
2
c
 (
C
D
C
l 3
) 
  
113 
 
 
 
 
2
5
2
5
5
0
5
0
7
5
7
5
1
0
0
1
0
0
1
2
5
1
2
5
1
5
0
1
5
0
1
75
1
7
5
2
00
2
0
0
O
O
O
O
H
3
.2
2
c
13
C
 N
M
R
 s
pe
ct
ru
m
 f
or
 k
et
o-
ac
id
 3
.2
2
c
 (
C
D
C
l 3
) 
  
114 
 
 
 
11
22
33
44
55
66
77
88
99
1010
1111
1212
O
O
3
.2
2
d
O
O
H
1 H
 N
M
R
 s
pe
ct
ru
m
 f
or
 k
et
o-
ac
id
 3
.2
2
d
 (
C
D
C
l 3
) 
  
115 
 
 
 
2525
5050
7575
10
0
10
0
12
5
12
5
15
0
15
0
17
5
17
5
20
0
20
0
O
O
3
.2
2
d
O
O
H
13
C
 N
M
R
 s
pe
ct
ru
m
 f
or
 k
et
o-
ac
id
 3
.2
2
d
 (
C
D
C
l 3
) 
  
116 
 
 
 
0.
5
0.
5
1.
0
1.
0
1.
5
1.
5
2.
0
2.
0
2.
5
2.
5
3.
0
3.
0
3.
5
3.
5
4.
0
4.
0
4.
5
4.
5
5.
0
5.
0
5.
5
5.
5
6.
0
6.
0
6.
5
6.
5
7.
0
7.
0
7.
5
7.
5
8.
0
8.
0
8.
5
8.
5
9.
0
9.
0
O
O
O
B
n
O
3
.3
2
1 H
 N
M
R
 s
pe
ct
ru
m
 f
or
 b
en
zy
l 
es
te
r 
3
.3
2
 (
C
D
C
l 3
) 
  
117 
 
 
 
 
 
 
2525
5050
7575
10
0
10
0
12
5
12
5
15
0
15
0
17
5
17
5
20
0
20
0
O
O
O
B
n
O
3
.3
2
13
C
 N
M
R
 s
pe
ct
ru
m
 f
or
 b
en
zy
l 
es
te
r 
3
.3
2
 (
C
D
C
l 3
) 
  
118 
 
 
 
0.
5
0.
5
1.
0
1.
0
1.
5
1.
5
2.
0
2.
0
2.
5
2.
5
3.
0
3.
0
3.
5
3.
5
4.
0
4.
0
4.
5
4.
5
5.
0
5.
0
5.
5
5.
5
6.
0
6.
0
6.
5
6.
5
7.
0
7.
0
7.
5
7.
5
8.
0
8.
0
8.
5
8.
5
9.
0
9.
0
O
O
O
O
B
n
3
.3
6
1 H
 N
M
R
 s
pe
ct
ru
m
 f
or
 b
en
zy
l 
es
te
r 
3
.3
6
 (
C
D
C
l 3
) 
  
119 
 
 
 
 
 
2525
5050
7575
10
0
10
0
12
5
12
5
15
0
15
0
17
5
17
5
20
0
20
0
O
O
O
O
B
n
3
.3
6
13
C
 N
M
R
 s
pe
ct
ru
m
 f
or
 b
en
zy
l 
es
te
r 
3
.3
6
 (
C
D
C
l 3
) 
  
120 
 
 
 
0.
5
0.
5
1.
0
1.
0
1.
5
1.
5
2.
0
2.
0
2.
5
2.
5
3.
0
3.
0
3.
5
3.
5
4.
0
4.
0
4.
5
4.
5
5.
0
5.
0
5.
5
5.
5
6.
0
6.
0
6.
5
6.
5
7.
0
7.
0
7.
5
7.
5
8.
0
8.
0
8.
5
8.
5
9.
0
9.
0
O
O
O
O
H
3
.3
7
1 H
 N
M
R
 s
pe
ct
ru
m
 f
or
 k
et
o-
ac
id
 3
.3
7
 (
C
D
C
l 3
) 
  
121 
 
 
 
2525
5050
7575
10
0
10
0
12
5
12
5
15
0
15
0
17
5
17
5
20
0
20
0
O
O
O
O
H
3
.3
7
13
C
 N
M
R
 s
pe
ct
ru
m
 f
or
 k
et
o-
ac
id
 3
.3
7
 (
C
D
C
l 3
) 
  
122 
 
 
 
0.
5
0.
5
1.
0
1.
0
1.
5
1.
5
2.
0
2.
0
2.
5
2.
5
3.
0
3.
0
3.
5
3.
5
4.
0
4.
0
4.
5
4.
5
5.
0
5.
0
5.
5
5.
5
6.
0
6.
0
6.
5
6.
5
7.
0
7.
0
7.
5
7.
5
8.
0
8.
0
8.
5
8.
5
9.
0
9.
0
N
O
O
B
n
3
.4
2
1 H
 N
M
R
 s
pe
ct
ru
m
 f
or
 i
m
in
e 
3
.4
2
 (
C
D
C
l 3
) 
  
123 
 
2525
5050
7575
10
0
10
0
12
5
12
5
15
0
15
0
17
5
17
5
20
0
20
0
N
O
O
B
n
3
.4
2
13
C
 N
M
R
 s
pe
ct
ru
m
 f
or
 i
m
in
e 
3
.4
2
 (
C
D
C
l 3
) 
  
124 
 
 
 
0.
5
0.
5
1.
0
1.
0
1.
5
1.
5
2.
0
2.
0
2.
5
2.
5
3.
0
3.
0
3.
5
3.
5
4.
0
4.
0
4.
5
4.
5
5.
0
5.
0
5.
5
5.
5
6.
0
6.
0
6.
5
6.
5
7.
0
7.
0
7.
5
7.
5
8.
0
8.
0
8.
5
8.
5
9.
0
9.
0
T
s
N
O
B
n
O
H
3
.4
4
1 H
 N
M
R
 s
pe
ct
ru
m
 f
or
 t
os
yl
 a
m
in
e 
3
.4
4
 (
C
D
C
l 3
) 
  
125 
 
 
 
 
 
O
3
.4
4
O
B
n
T
s
NH
13
C
 N
M
R
 s
pe
ct
ru
m
 f
or
 t
os
yl
 a
m
in
e 
3
.4
4
 (
C
D
C
l 3
) 
  
126 
 
 
 
0.
5
0.
5
1.
0
1.
0
1.
5
1.
5
2.
0
2.
0
2.
5
2.
5
3.
0
3.
0
3.
5
3.
5
4.
0
4.
0
4.
5
4.
5
5.
0
5.
0
5.
5
5.
5
6.
0
6.
0
6.
5
6.
5
7.
0
7.
0
7.
5
7.
5
8.
0
8.
0
8.
5
8.
5
9.
0
9.
0
T
sN
O
B
n
O
H
O
3
.4
5
1 H
 N
M
R
 s
pe
ct
ru
m
 f
or
 t
os
yl
 a
m
in
e 
3
.4
5
 (
C
D
C
l 3
) 
  
127 
 
 
2525
5050
7575
10
0
10
0
12
5
12
5
15
0
15
0
17
5
17
5
20
0
20
0
T
sN
O
B
n
O
H
O
3
.4
5
13
C
 N
M
R
 s
pe
ct
ru
m
 f
or
 t
os
yl
 a
m
in
e 
3
.4
5
 (
C
D
C
l 3
) 
  
128 
 
 
 
0.
5
0.
5
1.
0
1.
0
1.
5
1.
5
2.
0
2.
0
2.
5
2.
5
3.
0
3.
0
3.
5
3.
5
4.
0
4.
0
4.
5
4.
5
5.
0
5.
0
5.
5
5.
5
6.
0
6.
0
6.
5
6.
5
7.
0
7.
0
7.
5
7.
5
8.
0
8.
0
8.
5
8.
5
9.
0
9.
0
T
s
N
O
H
O
H
O
3
.4
6
1 H
 N
M
R
 s
pe
ct
ru
m
 f
or
 k
et
o-
ac
id
 3
.4
6
 (
C
D
3O
D
) 
  
129 
 
 
 
2525
5050
7575
10
0
10
0
12
5
12
5
15
0
15
0
17
5
17
5
20
0
20
0
T
s
N
O
H
O
H
O
3
.4
6
13
C
 N
M
R
 s
pe
ct
ru
m
 f
or
 k
et
o-
ac
id
 3
.4
6
 (
C
D
3O
D
) 
  
130 
 
 
 
0.
5
0.
5
1.
0
1.
0
1.
5
1.
5
2.
0
2.
0
2.
5
2.
5
3.
0
3.
0
3.
5
3.
5
4.
0
4.
0
4.
5
4.
5
5.
0
5.
0
5.
5
5.
5
6.
0
6.
0
6.
5
6.
5
7.
0
7.
0
7.
5
7.
5
8.
0
8.
0
8.
5
8.
5
9.
0
9.
0
O
O
O
3
.6
1
1 H
 N
M
R
 s
pe
ct
ru
m
 f
or
 a
ld
eh
yd
e 
3
.6
1
 (
C
D
C
l 3
) 
  
131 
 
 
 
O
O
O
3
.6
1
13
C
 N
M
R
 s
pe
ct
ru
m
 f
or
 a
ld
eh
yd
e 
3
.6
1
 (
C
D
C
l 3
) 
  
132 
APPENDIX B 
 
CRYSTALLOGRAPHIC DATA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
133 
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135 
  Table 17.  Crystal data and structure refinement for tricyclic β-lactone 3.19a. 
Identification code  p21 
Empirical formula  C11 H14 O3 
Formula weight  194.22 
Temperature  140(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1) 
Unit cell dimensions a = 6.773(3) Å α= 90°. 
 b = 18.993(9) Å β= 90.046(5)°. 
 c = 7.715(4) Å γ = 90°. 
Volume 992.3(8) Å3 
Z 4 
Density (calculated) 1.300 Mg/m3 
Absorption coefficient 0.094 mm-1 
F(000) 416 
Crystal size 0.19 x 0.05 x 0.05 mm3 
Theta range for data collection 2.64 to 28.48°. 
Index ranges -8<=h<=8, -24<=k<=24, -10<=l<=10 
Reflections collected 11258 
Independent reflections 4593 [R(int) = 0.0454] 
Completeness to theta = 28.48° 94.7 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9953 and 0.9824 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4593 / 1 / 256 
Goodness-of-fit on F2 1.039 
Final R indices [I>2sigma(I)] R1 = 0.0479, wR2 = 0.0840 
R indices (all data) R1 = 0.0667, wR2 = 0.0915 
Absolute structure parameter 0.2(14) 
Largest diff. peak and hole 0.167 and -0.220 e.Å-3 
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Table 18.  Crystal data and structure refinement for tricyclic β-lactone (syn)-3.19c. 
Identification code  drb0628g 
Empirical formula  C12 H16 O3 
Formula weight  208.25 
Temperature  110(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/n 
Unit cell dimensions a = 10.8422(9) Å α= 90°. 
 b = 7.1838(6) Å β= 110.0990(10)°. 
 c = 14.0565(12) Å γ = 90°. 
Volume 1028.16(15) Å3 
Z 4 
Density (calculated) 1.345 Mg/m3 
Absorption coefficient 0.096 mm-1 
F(000) 448 
Crystal size 0.30 x 0.20 x 0.20 mm3 
Theta range for data collection 2.06 to 27.54°. 
Index ranges -14<=h<=14, -9<=k<=9, -18<=l<=18 
Reflections collected 11410 
Independent reflections 2374 [R(int) = 0.0332] 
Completeness to theta = 27.54° 99.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9812 and 0.9719 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2374 / 0 / 137 
Goodness-of-fit on F2 1.104 
Final R indices [I>2sigma(I)] R1 = 0.0416, wR2 = 0.0960 
R indices (all data) R1 = 0.0476, wR2 = 0.0991 
Largest diff. peak and hole 0.343 and -0.186 e.Å-3 
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  Table 19.  Crystal data and structure refinement for (anti)-tricyclic β-lactone 3.19c. 
Identification code  drb0626g 
Empirical formula  C12 H16 O3 
Formula weight  208.25 
Temperature  110(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 8.751(2) Å α= 112.543(4)°. 
 b = 11.521(3) Å β= 97.399(5)°. 
 c = 11.735(3) Å γ = 101.084(5)°. 
Volume 1045.2(5) Å3 
Z 4 
Density (calculated) 1.323 Mg/m3 
Absorption coefficient 0.094 mm-1 
F(000) 448 
Crystal size 0.50 x 0.40 x 0.05 mm3 
Theta range for data collection 1.93 to 27.53°. 
Index ranges -11<=h<=11, -14<=k<=14, -15<=l<=15 
Reflections collected 12096 
Independent reflections 4730 [R(int) = 0.0328] 
Completeness to theta = 27.53° 98.5 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9953 and 0.9545 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4730 / 0 / 273 
Goodness-of-fit on F2 1.036 
Final R indices [I>2sigma(I)] R1 = 0.0439, wR2 = 0.0950 
R indices (all data) R1 = 0.0569, wR2 = 0.1006 
Largest diff. peak and hole 0.367 and -0.186 e.Å-3 
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Table 20.  Crystal data and structure refinement for (syn)-tricyclic β-lactone 3.19d. 
Identification code  drb08070g 
Empirical formula  C13 H18 O3 
Formula weight  222.27 
Temperature  110(2) K 
Wavelength  1.54178 Å 
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2(1) 
Unit cell dimensions a = 7.1697(3) Å α= 90°. 
 b = 10.7054(4) Å β= 90°. 
 c = 14.4136(6) Å γ = 90°. 
Volume 1106.31(8) Å3 
Z 4 
Density (calculated) 1.335 Mg/m3 
Absorption coefficient 0.757 mm-1 
F(000) 480 
Crystal size 0.30 x 0.20 x 0.02 mm3 
Theta range for data collection 5.15 to 60.85°. 
Index ranges -8<=h<=7, -12<=k<=12, -16<=l<=16 
Reflections collected 7641 
Independent reflections 1677 [R(int) = 0.0371] 
Completeness to theta = 60.85° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9850 and 0.8048 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1677 / 0 / 147 
Goodness-of-fit on F2 1.048 
Final R indices [I>2sigma(I)] R1 = 0.0291, wR2 = 0.0721 
R indices (all data) R1 = 0.0324, wR2 = 0.0739 
Absolute structure parameter 0.5(2) 
Largest diff. peak and hole 0.141 and -0.159 e.Å-3 
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